Processing 00000000.tx.1: Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on -Amyloid Peptide Fibrils* Andrew Lockhart, Liang Ye, Duncan B. 

Phrase: "Evidence for the Presence of Three Distinct Binding Sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "for the Thioflavin T Class"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "of Alzheimer's Disease PET Imaging Agents on -Amyloid Peptide Fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   809   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0225328:fibrils [Cell Component]
   755 E C1948066:Fibril [Physical Object]

Phrase: "* Andrew Lockhart,"

Phrase: "Liang Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]

Phrase: "Duncan B."
Processing 00000000.tx.2: Judd, Andy T. 

Phrase: "Judd,"

Phrase: "Andy T."
Processing 00000000.tx.3: Merritt, Peter N. 

Phrase: "Merritt,"

Phrase: "Peter N."
Processing 00000000.tx.4: Lowe||, Jennifer L. 

Phrase: "Lowe||,"

Phrase: "Jennifer L."
Processing 00000000.tx.5: Morgenstern, Guizhu Hong, Antony D. 

Phrase: "Morgenstern,"

Phrase: "Guizhu Hong,"

Phrase: "Antony D."
Processing 00000000.tx.6: Gee, and John Brown From the Translational Medicine and Technology, GlaxoSmithKline Research and Development, Addenbrookes Hospital, Cambridge CB2 2GG and High Throughput Chemistry and ||Molecular Interactions, GlaxoSmithKline Research and Development, Medicine Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom Received for publication, October 25, 2004 , and in revised form, December 14, 2004.  

Phrase: "Gee,"

Phrase: "and"

Phrase: "John Brown From the Translational Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "GlaxoSmithKline Research and Development,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0035170:Research and Development [Research Activity]
           RESEARCH DEVELOPMENT
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   741 E C0458003:Developmental [Qualitative Concept]

Phrase: "Addenbrookes Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Cambridge CB2 2GG"

Phrase: "and"

Phrase: "High Throughput Chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007996:Chemistry [Occupation or Discipline]
   827   C0079107:chemistry [Classification]
   827   C0201682:Chemistry [Laboratory Procedure]

Phrase: "and ||"

Phrase: "Molecular Interactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1167622:Molecular Interaction [Molecular Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "GlaxoSmithKline Research and Development,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0035170:Research and Development [Research Activity]
           RESEARCH DEVELOPMENT
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   741 E C0458003:Developmental [Qualitative Concept]

Phrase: "Medicine Research Centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Gunnels Wood Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "Stevenage SG1 2NY,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 25,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 14,"

Phrase: "2004."
Processing 00000000.tx.7: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Imaging the progression of Alzheimer's disease would greatly facilitate the discovery of therapeutics, and a wide range of ligands are currently under development for the detection of -amyloid peptide (A)-containing plaques by using positron emission tomography. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "the progression of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0242656:Disease Progression [Pathologic Function]
           progression
   797   C1947900:Disease progression NOS [Finding]
   760   C0449258:Progression [Functional Concept]

Phrase: "would"

Phrase: "greatly"

Phrase: "facilitate"

Phrase: "the discovery of therapeutics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880355:Discovery [Activity]

Phrase: "and"

Phrase: "a wide range of ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "are"

Phrase: "currently under development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0521116:Currently [Temporal Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "for the detection of -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)-containing plaques by"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0333463:plaques [Acquired Abnormality]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "positron emission tomography."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]
Processing 00000000.tx.8: Here we report an in-depth characterization of the binding of seven previously described ligands to in vitro generated A-(140) polymers. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "an in-depth characterization of the binding of seven previously described ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "to in vitro generated A-(140"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0021135:In Vitro [Intellectual Product]
   840   C1533691:in vitro [Qualitative Concept]
           vitro
   840   C2827718:In Vitro [Functional Concept]
   804   C3146294:Generated [Activity]

Phrase: ")"

Phrase: "polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]
Processing 00000000.tx.9: All of the compounds were derived from the benzothiazole compound thioflavin T and include 2-[4'-(methylamino)phenyl]benzothiazole and 2-(4'-dimethylamino-)phenyl-imidazo[1,2-a]-pyridine derivatives, 2-[4'-(dimethylamino)phenyl]-6-iodobenzothiazole and 2-[4'-(4''-methylpiperazin-1-yl)phenyl]-6-iodobenzothiazole, and a benzofuran compound (5-bromo-2-(4-dimethylaminophenyl)benzofuran). 

Phrase: "All of the compounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "were"

Phrase: "derived from the benzothiazole compound thioflavin T"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0053246:benzothiazole [Organic Chemical]
   748   C0205198:Compound [Qualitative Concept]
   748   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1441547:Derived [Qualitative Concept]
   748   C1706082:Compound [Chemical]
   748   C3245521:derived [Idea or Concept]
   748   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(methylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]benzothiazole"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "and"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(4'-dimethylamino-"

Phrase: ")"

Phrase: "phenyl-imidazo"

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-a]-pyridine derivatives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243072:derivatives [Chemical Viewed Structurally]
   779 E C1527240:Derivative [Functional Concept]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(dimethylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole"

Phrase: "and"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(4''-methylpiperazin-1-yl"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole,"

Phrase: "and"

Phrase: "a benzofuran compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "(5-bromo-2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(4-dimethylaminophenyl"

Phrase: ")"

Phrase: "benzofuran"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005068:Benzofuran [Organic Chemical]
  1000   C0537916:benzofuran [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.10: By using a range of fluorescent and radioligand binding assays, we find that these compounds display a more complex binding pattern than described previously and are consistent with three classes of binding sites on the A fibrils. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a range of fluorescent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "radioligand binding assays,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0034596:Radioligand Assays [Laboratory Procedure]
   827   C0243122:binding [Functional Concept]
   827   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "these compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a more complex binding pattern than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1523331:pattern binding [Molecular Function]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "and"

Phrase: "are"

Phrase: "consistent with three classes of binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the"

Phrase: "A fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.11: All of the compounds bound with very high affinity (low nM Kd) to a low capacity site (BS3) (1 ligand-binding site per 300 A-(140) monomers) consistent with the previously recognized binding site for these compounds on the fibrils. 

Phrase: "All of the compounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "bound with very high affinity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0442804:Very high [Finding]
   760   C0205250:High [Qualitative Concept]
   760   C0332297:bound [Spatial Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(low nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Kd) to a low capacity site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026691:KD [Disease or Syndrome]
   753   C1705240:KD [Gene or Genome]
   753   C1839259:KD [Disease or Syndrome]

Phrase: "(BS3"

Phrase: ")"

Phrase: "(1 ligand-binding site per 300 A-(140"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   770   C1517880:Ligand Binding [Molecular Function]
   744   C0023688:Ligand [Chemical]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "consistent with the previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "recognized"

Phrase: "binding site for these compounds"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "on the fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.12: However, the compounds also bound with high affinity (Kd 100 nM) to either one of two additional binding sites on the A-(140) polymer. 

Phrase: "However,"

Phrase: "the compounds also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "bound with high affinity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205250:High [Qualitative Concept]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "(Kd 100 nM) to either one of two additional binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0312860:NM [Cell Function]

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "polymer."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]
Processing 00000000.tx.13: The properties of these sites, BS1 and BS2, suggest they are adjacent or partially overlapping and have a higher capacity than BS3, occurring every 35 or every 4 monomers of A-(140)-peptide, respectively. 

Phrase: "The properties of these sites,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "BS1"

Phrase: "and"

Phrase: "BS2,"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "they"

Phrase: "are"

Phrase: "adjacent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205117:Adjacent [Spatial Concept]
   928 E C3242705:adjacency [Idea or Concept]

Phrase: "or"

Phrase: "partially"

Phrase: "overlapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]

Phrase: "and"

Phrase: "have"

Phrase: "a higher capacity than BS3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516240:Capacity [Quantitative Concept]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "every 35"

Phrase: "or"

Phrase: "every 4 monomers of A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")-"

Phrase: "peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "respectively."
Processing 00000000.tx.14: Compounds appear to display selectivity for BS2 based on the presence of a halogen substitution (2-[4'-(dimethylamino)phenyl]-6-iodobenzothiazole, 2-[4'-(4''-methylpiperazin-1-yl)phenyl]-6-iodobenzothiazole, and 5-bromo-2-(4-dimethylaminophenyl)benzofuran) on their aromatic ring system. 

Phrase: "Compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "selectivity for BS2"

Phrase: "based on the presence of a halogen substitution"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0018544:Halogen [Element, Ion, or Isotope]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1527178:Based [Functional Concept]
   744   C1555721:Substitution [Idea or Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1706204:Substitution [Activity]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(dimethylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole,"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(4''-methylpiperazin-1-yl"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole,"

Phrase: "and"

Phrase: "5-bromo-2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(4-dimethylaminophenyl"

Phrase: ")"

Phrase: "benzofuran"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005068:Benzofuran [Organic Chemical]
  1000   C0537916:benzofuran [Organic Chemical]

Phrase: ")"

Phrase: "on their aromatic ring system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.15: The presence of additional ligand-binding sites presents potential new targets for ligand development and may allow a more complete modeling of the current positron emission tomography data.  

Phrase: "The presence of additional ligand-binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "potential new targets for ligand development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "may"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "modeling of the current positron emission tomography data."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0870071:Modeling [Intellectual Product,Research Activity]
Processing 00000000.tx.16: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Alzheimer's disease (AD)1 is a common neurological disease of chronic dementia, memory loss, and cognitive impairment. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "a common neurological disease of chronic dementia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0027765:neurological disease [Disease or Syndrome]
   774   C0008679:Chronic disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]

Phrase: "memory loss,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002622:Memory loss [Mental or Behavioral Dysfunction]
  1000   C0751295:Memory Loss [Sign or Symptom]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "cognitive impairment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.17: Central to the neuropathology of AD is the deposition in specific brain regions of polymeric peptide/protein deposits, composed of -amyloid peptide (A) and tau protein, termed senile plaques (SPs) and neurofibrillary tangles (NFTs), respectively (reviewed in Ref. 1). 

Phrase: "Central to the neuropathology of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205099:Central [Spatial Concept]
   753   C1879652:Central - [Laboratory Procedure]

Phrase: "is"

Phrase: "the deposition in specific brain regions of polymeric peptide/protein deposits,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0333584:Protein deposition [Pathologic Function]
   738   C0333562:Deposition [Functional Concept]

Phrase: "composed"

Phrase: "of -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "tau protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "senile plaques (SPs)"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neurofibrillary tangles (NFTs),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "respectively"

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.18: The precise role of these deposits in the pathogenesis of AD is still unclear. 

Phrase: "The precise role of these deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of AD"

Phrase: "is"

Phrase: "still unclear."
Processing 00000000.tx.19: However, individuals with mutations leading to increased A production are at a high risk of developing AD (2), and individuals with mutations in the tau gene are linked to a class of neurodegenerative diseases including frontotemporal dementia and parkinsonism linked to chromosome 17 (3). 

Phrase: "However,"

Phrase: "individuals with mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "leading to increased"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   841   C0861064:increased lead [Finding]
   790   C0205217:Increased [Quantitative Concept]
   790   C0332152:Leading [Temporal Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "are at a high risk of developing AD (2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0332167:High risk of [Qualitative Concept]
           High Risk
   764   C3272283:High Risk [Finding]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205250:High [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1551058:Are [Quantitative Concept]
   742   C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "individuals with mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "in the tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "linked to a class of neurodegenerative diseases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0456387:Class [Intellectual Product]
   748   C1705943:Class [Classification]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: Moreover, the accumulation of SPs and NFTs follows a predictable temporal and spatial sequence in individuals affected with AD (4, 5). 

Phrase: "Moreover,"

Phrase: "the accumulation of SPs"

Phrase: "and"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "a predictable temporal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442043:Temporal [Spatial Concept]
   861   C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "spatial sequence in individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "affected with AD (4,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: Detection of these deposits may therefore provide a clinically useful tool for monitoring disease progression and treatment effects. 

Phrase: "Detection of these deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "therefore"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a clinically useful tool for monitoring disease progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0336791:Tool [Manufactured Object]
   744   C2827396:Tool [Manufactured Object]
   731   C0871532:tool use [Finding]

Phrase: "and"

Phrase: "treatment effects."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   966   C1518681:Treatment Effect [Finding]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1280500:effects [Qualitative Concept]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.22: Positron emission tomography (PET) uses positron emitting radioligands to image and measure ligand-binding sites in vivo and is currently being developed as a sensitive way to track SPs and NFTs in patients (reviewed in Ref. 6). 

Phrase: "Positron emission tomography (PET)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "positron emitting radioligands to image"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "measure ligand-binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0005456:Binding Sites [Receptor]
   861   C1517880:Ligand Binding [Molecular Function]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0023688:Ligand [Chemical]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "is"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "being"

Phrase: "developed as a sensitive way to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]

Phrase: "track"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "SPs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "NFTs in patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "("

Phrase: "reviewed in Ref. 6"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.23: Three broad categories of PET ligands of AD-associated polymers are currently under investigation. 

Phrase: "Three broad categories of PET ligands of AD-associated polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0683312:Categories [Intellectual Product]
   703 E C1555713:category [Idea or Concept]

Phrase: "are"

Phrase: "currently under investigation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0521116:Currently [Temporal Concept]
   790   C1261322:Investigation [Health Care Activity]
   790   C1552578:investigation [Idea or Concept]
   718 E C1517586:Investigational [Qualitative Concept]
   718 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.24: One class is derived from the dye thioflavin T (Thio T) and includes BTA/PIB (7, 8), IMPY (9), TZDM, and TZPI (10). 

Phrase: "One class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "is"

Phrase: "derived from the dye thioflavin T (Thio T)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   753   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "BTA/PIB"

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "IMPY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "TZDM,"

Phrase: "and"

Phrase: "TZPI"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.25: A second class is characterized by a styrylbenzene backbone and includes X34 (11), X04 (12), IMSB (10), BSB (10), and the stilbenes (13). 

Phrase: "A second class"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0205436:Second [Quantitative Concept]
   861   C0456387:Class [Intellectual Product]
   861   C0457385:Second [Temporal Concept]
   861   C0565930:/second [Quantitative Concept]
   861   C1561503:second [Idea or Concept]
   861   C1705190:Second [Qualitative Concept]
   861   C1705943:Class [Classification]
   789 E C0027627:secondary [Neoplastic Process]
   789 E C0175668:Secondary [Temporal Concept]

Phrase: "is"

Phrase: "characterized by a styrylbenzene backbone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037949:Backbone [Body Part, Organ, or Organ Component]
   760   C1267072:Backbone [Body Part, Organ, or Organ Component]
   760   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "X34"

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "X04"

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "IMSB"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "BSB"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the stilbenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038333:Stilbenes [Organic Chemical]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.26: The final class has an aminonaphthyl core and includes FENE and FDDNP (14). 

Phrase: "The final class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "has"

Phrase: "an aminonaphthyl core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "FENE"

Phrase: "and"

Phrase: "FDDNP"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.27: The binding of these compounds to A-(140) fibrils generated in vitro has been investigated in a number of laboratories, and the results of these studies so far are consistent with three independent binding sites, one for each structural class of ligand, and all with high binding affinities. 

Phrase: "The binding of these compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "investigated in a number of laboratories,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0022877:Laboratories [Manufactured Object,Organization]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C1292732:investigated [Functional Concept]
   753   C1619828:Laboratories [Intellectual Product]
   719 E C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "the results of these studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "are"

Phrase: "consistent with three independent binding sites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "one for each structural class of ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "all with high binding affinities."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205250:High [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0444868:All [Quantitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   760   C3539085:All [Idea or Concept]
   726   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.28: However, the binding stoichiometry for all these structural classes of ligand has been reported to be low, with ligand-binding sites occurring only every few hundreds (8) or even thousands (14) of A-(140) monomers, and this raises a question of whether the signal to be anticipated from further development of these radioligands will be clinically useful. 

Phrase: "However,"

Phrase: "the binding stoichiometry for all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "these structural classes of ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456387:Class [Intellectual Product]
   760   C1705943:Class [Classification]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "with ligand-binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0005456:Binding Sites [Receptor]
   901   C1517880:Ligand Binding [Molecular Function]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0023688:Ligand [Chemical]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "every few hundreds"

Phrase: "(8"

Phrase: ")"

Phrase: "or"

Phrase: "even thousands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883310:Thousand [Quantitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "of A-(140"

Phrase: ")"

Phrase: "monomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "this"

Phrase: "raises"

Phrase: "a question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "the signal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "be"

Phrase: "anticipated from further development of these radioligands"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1517331:Further [Spatial Concept]
   748   C1527148:Development [Functional Concept]
   714 E C0205108:far [Spatial Concept]
   714   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]

Phrase: "will"

Phrase: "be"

Phrase: "clinically useful."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]
Processing 00000000.tx.29: Two of the ligands 6-OH-BTA-1/PIB and FDDNP have so far progressed to in vivo imaging studies (15, 16), comparing small numbers of control and AD patients. 

Phrase: "Two of the ligands 6-OH-BTA-1/PIB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "FDDNP"

Phrase: "have"

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "progressed to in vivo imaging studies"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   833   C1708481:In Vivo Imaging [Laboratory Procedure]
   804   C0681829:in vivo study [Research Activity]
           studies vivo
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   756   C1881134:Image Study [Diagnostic Procedure]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0947630:studies [Laboratory Procedure]
   753   C1272688:progressed [Functional Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C1280477:Progress [Functional Concept]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C2603343:Study [Research Activity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "small numbers of control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.30: The results demonstrate increased retention of labeled species in areas of the brain thought to be affected by AD. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "increased retention of labeled species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035280:Retention [Mental Process]
   760   C0333117:Retention [Functional Concept]
   760   C1753315:retention [Cell Function]

Phrase: "in areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205146:areas [Spatial Concept]
   966 E C0017446:Area [Geographic Area]

Phrase: "of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "affected by AD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.31: However, the precise nature of the signal in these studies remains uncertain given the low density of ligand-binding sites apparently present on A fibrils. 

Phrase: "However,"

Phrase: "the precise nature of the signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "in these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "remains"

Phrase: "uncertain given"

Phrase: "the low density of ligand-binding sites apparently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0178587:density [Quantitative Concept]
   744   C0205251:low [Qualitative Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1550472:low [Idea or Concept]

Phrase: "present on A fibrils."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0225328:fibrils [Cell Component]
   770   C0449450:Present [Idea or Concept]
   737 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.32: The situation is further complicated by ex vivo measurement of PIB binding to brain homogenates obtained post-mortem from patients with AD (8). 

Phrase: "The situation"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "complicated by ex vivo measurement of PIB binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C2348480:ex vivo [Functional Concept]
   744   C0231242:Complicated [Functional Concept]
   744   C0242485:Measurement [Functional Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515655:vivo [Spatial Concept]

Phrase: "to brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "post-mortem from patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0004398:postmortem [Diagnostic Procedure]
   833   C0580205:Postmortem [Temporal Concept]
   833   C0848632:post mortem [Finding]
   770   C0687676:Post [Temporal Concept]
   770   C1704687:Post [Manufactured Object]

Phrase: "with AD (8"

Phrase: ")."
Processing 00000000.tx.33: A peptides were not measured in this study but were interpolated from a different study by Nslund et al. 

Phrase: "A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "measured in this study"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0444706:Measured [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "but"

Phrase: "were"

Phrase: "interpolated from a different study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0557651:Study [Manufactured Object]
   760   C1705242:Different [Qualitative Concept]
   760   C2603343:Study [Research Activity]

Phrase: "by Nslund et al."
Processing 00000000.tx.34: (17). 

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.35: The conclusion was a binding stoichiometry approaching 1:1, much higher than all reports based on the direct study of A fibrils in vitro (8). 

Phrase: "The conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "was"

Phrase: "a binding stoichiometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "approaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:approaching [Spatial Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "much higher than all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "based on the direct study of A fibrils"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   744   C0225328:fibrils [Cell Component]
   744   C0439851:Direct [Qualitative Concept]
   744   C0557651:Study [Manufactured Object]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1947931:Direct [Qualitative Concept]
   744   C2603343:Study [Research Activity]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C1948066:Fibril [Physical Object]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.36: The binding properties of the ligands to A fibrils have all been characterized by using essentially identical filter binding assays employing either narrow ranges of radioligand to determine Kd values (10, 13) or a single fixed low concentration of radioligand and varying concentrations of cold competitor (7, 18). 

Phrase: "The binding properties of the ligands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "to A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "have"

Phrase: "all"

Phrase: "been"

Phrase: "characterized by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1880022:Characterized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "essentially identical filter binding assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "either narrow ranges of radioligand to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1514721:*Ranges [Quantitative Concept]
   719 E C2348147:Range [Quantitative Concept]
   719 E C3542016:Range [Intellectual Product]

Phrase: "determine"

Phrase: "Kd values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0026691:KD [Disease or Syndrome]
   861   C0042295:Values [Qualitative Concept]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(10,"

Phrase: "13"

Phrase: ")"

Phrase: "or"

Phrase: "a single fixed low concentration of radioligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "varying concentrations of cold competitor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(7,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.37: The former assay format will only generally detect very high affinity binding as lower affinity interactions dissociate during the filter washing step, whereas the latter format is a site-specific assay and will not be sensitive to novel ligand-binding sites. 

Phrase: "The former assay format"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1301627:Format [Intellectual Product]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "will"

Phrase: "only generally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "very high affinity binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0442804:Very high [Finding]
   812   C0205250:High [Qualitative Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1299351:High [Qualitative Concept]
   812   C1510827:Affinity [Natural Phenomenon or Process]
   812   C2700149:HIGH [Intellectual Product]

Phrase: "as"

Phrase: "lower affinity interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "dissociate during the filter washing step,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0180860:Filter [Manufactured Object]
   753   C0441648:Washing [Activity]
   753   C0581406:Filter [Medical Device]
   753   C1261552:Step [Conceptual Entity]
   753   C1522664:Filter [Intellectual Product]
   753   C1704379:Step [Functional Concept]
   753   C1704449:Filter [Conceptual Entity]
   753   C1704684:Filter [Medical Device]
   753   C1705117:Step [Quantitative Concept]
   753   C1875155:FILTER [Medical Device]
   753   C2825408:Step [Manufactured Object]

Phrase: "whereas"

Phrase: "the latter format"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301627:Format [Intellectual Product]

Phrase: "is"

Phrase: "a site-specific assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0449604:site specific [Spatial Concept]

Phrase: "and"

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "sensitive to novel ligand-binding sites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.38: The results of these assays have not yet been confirmed by other ligand-binding techniques. 

Phrase: "The results of these assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "confirmed by other ligand-binding techniques."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C1517880:Ligand Binding [Molecular Function]
   753   C0023688:Ligand [Chemical]
   753   C0025664:techniques [Intellectual Product]
   753   C0243122:binding [Functional Concept]
   753   C0449851:Techniques [Functional Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.39: We have addressed these issues by developing a series of homogeneous binding assays that take advantage of the intrinsic fluorescence of both Thio T and a number of representative derivative compounds to measure their binding properties over a wide range of ligand and A fibril concentrations. 

Phrase: "We"

Phrase: "have"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "these issues by developing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0033213:Issue [Finding]
   737   C1706387:Issue [Intellectual Product]

Phrase: "a series of homogeneous binding assays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "that"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "advantage of the intrinsic fluorescence of both Thio T"

Phrase: "and"

Phrase: "a number of representative derivative compounds to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "their binding properties over a wide range of ligand"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0871161:properties [Qualitative Concept]
   742   C1292721:properties [Functional Concept]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "A fibril concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.40: The results of these assays were compared with classical radioligand binding assays and are consistent with the presence of the previously described low density ligand-binding site but also demonstrate the presence of additional higher density ligand-binding sites on the fibrils. 

Phrase: "The results of these assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "were"

Phrase: "compared with classical radioligand binding assays"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0034596:Radioligand Assays [Laboratory Procedure]
   753   C0243122:binding [Functional Concept]
   753   C0439858:Classical [Qualitative Concept]
   753   C0443177:Classical [Functional Concept]
   753   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1707455:Compared [Activity]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "are"

Phrase: "consistent with the presence of the previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "low density ligand-binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0005456:Binding Site [Receptor]
   840   C0682969:Binding Site [Amino Acid Sequence]
   840   C1517880:Ligand Binding [Molecular Function]
   804   C0023688:Ligand [Chemical]
   804   C0205145:Site [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "but"

Phrase: "also"

Phrase: "demonstrate"

Phrase: "the presence of additional higher density ligand-binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on the fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.41: The selectivity of these additional sites and their potential significance for the innovation of selective PET radioligands for the clinical investigation of AD and its treatments are discussed.  

Phrase: "The selectivity of these additional sites"

Phrase: "and"

Phrase: "their potential significance for the innovation of selective PET radioligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0237881:Significance [Quantitative Concept]
   736   C0750502:Significance [Idea or Concept]

Phrase: "for the clinical investigation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1261322:Clinical investigation [Health Care Activity]
           Investigation
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "of AD"

Phrase: "and"

Phrase: "its treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "discussed."
Processing 00000000.tx.42: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Compound Names and SourcesThe structures of the compounds employed in this study are shown in Fig. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Compound Names"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027365:Name [Intellectual Product]
   861   C1547383:Name [Intellectual Product]

Phrase: "and"

Phrase: "SourcesThe"

Phrase: "structures of the compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678594:Structure [Spatial Concept]
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "employed in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0557351:Employed [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0457083:Employ [Functional Concept]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.43: 1 and are as follows: thioflavin T (Thio T); 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "thioflavin T (Thio T"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.44: 2-[4'-(methylamino)phenyl]benzothiazole (BTA-1) (19); 

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(methylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]benzothiazole (BTA-1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(19"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.45: 2-[4'-(methylamino)phenyl]-6-methylbenzothiazole (6-Me-BTA-1) (7); 

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(methylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-methylbenzothiazole"

Phrase: "(6-Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0053246:benzothiazole [Organic Chemical]
   827   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "(7"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.46: 2-(4'-dimethylamino-)phenylimidazo[1,2-a]-pyridine (IMPY-H) (9); 

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(4'-dimethylamino-"

Phrase: ")"

Phrase: "phenylimidazo"

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-a]-pyridine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034251:pyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0034255:Pyridine [Organic Chemical]

Phrase: "(IMPY-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "IMPY-H) (9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0067456:H-9 [Organic Chemical,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0205090:R- [Spatial Concept]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.47: 6-methyl-2-(4'-dimethylamino-)phenylimidazo[1,2-a]-pyridine (IMPY-Me) (9); 

Phrase: "6-methyl-2-"

Phrase: "(4'-dimethylamino-"

Phrase: ")"

Phrase: "phenylimidazo"

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-a]-pyridine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034251:pyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0034255:Pyridine [Organic Chemical]

Phrase: "(IMPY-Me) (9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.48: 2-[4'-(dimethylamino)phenyl]-6-iodobenzothiazole (TZDM) (10); 

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(dimethylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole"

Phrase: "(TZDM"

Phrase: ")"

Phrase: "(10"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.49: 2-[4'-(4''-methylpiperazin-1-yl)phenyl]-6-iodobenzothiazole (TZPI) (10); 

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(4''-methylpiperazin-1-yl"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole"

Phrase: "(TZPI"

Phrase: ")"

Phrase: "(10"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.50: and 5-bromo-2-(4-dimethylaminophenyl)benzofuran (BF1) (20). 

Phrase: "and"

Phrase: "5-bromo-2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(4-dimethylaminophenyl"

Phrase: ")"

Phrase: "benzofuran"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005068:Benzofuran [Organic Chemical]
  1000   C0537916:benzofuran [Organic Chemical]

Phrase: "(BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: ")"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.51: Thio T was obtained from Merck. 

Phrase: "Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "obtained from Merck."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.52: The remainder of the compounds was custom-synthesized and confirmed for purity by reverse-phase high pressure liquid chromatography, one-dimensional NMR, and mass spectrometer analysis. 

Phrase: "The remainder of the compounds"

Phrase: "was"

Phrase: "custom-synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "confirmed for purity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C1882508:Purity [Quantitative Concept]
   756 E C1456348:Confirm [Qualitative Concept]
   718 E C2247561:PurE [Molecular Function]

Phrase: "by reverse-phase high pressure liquid chromatography,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   913   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   904   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   901   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   827   C0008565:Liquid Chromatography [Laboratory Procedure]
   799   C0008550:Chromatography [Laboratory Procedure]
   799   C0033095:Pressure [Phenomenon or Process]
   799   C0205250:High [Qualitative Concept]
   799   C0302908:Liquid [Substance]
   799   C0460139:Pressure [Finding]
   799   C1299351:High [Qualitative Concept]
   799   C1304698:Liquid [Finding]
   799   C1306345:Pressure [Functional Concept]
   799   C1546699:Liquid NOS [Intellectual Product]
   799   C1561501:Liquid NOS [Substance]
   799   C2700149:HIGH [Intellectual Product]

Phrase: "one-dimensional NMR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0024485:NMR [Diagnostic Procedure]
   827   C0028580:NMR [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "mass spectrometer analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0183396:Mass Spectrometer [Medical Device]
Processing 00000000.tx.53: Radiolabeled 2-[4'-([3H]methylamino)phenyl]-6-methylbenzothiazole ([3H]Me-BTA-1) (84 Ci/mmol, 1 mCi/ml) was custom-synthesized by Amersham Biosciences. 

Phrase: "Radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "("

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]methylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-methylbenzothiazole"

Phrase: "("

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "(84 Ci/mmol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "1 mCi/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0560005:mCi [Quantitative Concept]
   861   C1270972:MCI [Mental or Behavioral Dysfunction]
   861   C3463911:MCI [Gene or Genome]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "custom-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0162343:Custom [Idea or Concept]
  1000   C1880202:Custom [Activity]
   928 E C3242380:customary [Intellectual Product]
   928 E C3538928:Customary [Qualitative Concept]

Phrase: "synthesized by Amersham Biosciences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883254:Synthesized [Activity]
Processing 00000000.tx.54: All other chemicals were from Sigma with the exceptions of Congo Red and phosphotungstic acid that were obtained from Gee Lawson (London, UK) and Agar Scientific (Stansted, UK). 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]

Phrase: "with the exceptions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1554961:exception [Idea or Concept]
   966   C1705847:Exception [Conceptual Entity]

Phrase: "of Congo Red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0009738:Congo [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "phosphotungstic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031730:Phosphotungstic Acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "were"

Phrase: "obtained from Gee Lawson (London,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0023973:London [Geographic Area]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "UK"

Phrase: ")"

Phrase: "and"

Phrase: "Agar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001771:Agar [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: "(Stansted,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.55: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.56: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.57: Compound structures. 

Phrase: "Compound structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]
Processing 00000000.tx.58: A, Thio T; 

Phrase: "A,"

Phrase: "Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.59: B, BTA, R=H (BTA-1)/CH3 (6Me-BTA-1); 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "BTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519830:BTA [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "R=H (BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0053246:benzothiazole [Organic Chemical]
   827   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "/CH3"

Phrase: "(6Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.60: C, IMPY, R=H (IMPY-H)/CH3 (IMPY-Me); 

Phrase: "C,"

Phrase: "IMPY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "R=H (IMPY-H)/CH3"

Phrase: "(IMPY-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "Me"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.61: D, TZDM; 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TZDM"

Phrase: ";"
Processing 00000000.tx.62: E, TZPI; 

Phrase: "E,"

Phrase: "TZPI"

Phrase: ";"
Processing 00000000.tx.63: and F, BF1. 

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "BF1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]
Processing 00000000.tx.64: Full compound nomenclatures are provided under "Compound Names and Sources."  

Phrase: "Full compound nomenclatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0600281:nomenclatures [Intellectual Product]
   793 E C1524067:Nomenclature [Intellectual Product]

Phrase: "are"

Phrase: "provided under ""Compound Names"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0027365:Name [Intellectual Product]
   770   C0205198:Compound [Qualitative Concept]
   770   C1547383:Name [Intellectual Product]
   770   C1706082:Compound [Chemical]
   770   C1999230:Provided [Activity]

Phrase: "and"

Phrase: "Sources."""
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449416:sources [Finding]
   966 E C1705919:Source [Idea or Concept]
Processing 00000000.tx.65: Preparation of A-(140) FibrilsHuman A-(140)-peptide (Batch number MK0611 from California Peptide Research, Napa, CA) was incubated at 0.5 mg/ml in PB buffer (10 mM sodium phosphate, 1 mM EDTA, pH 7.4) at 37 C for 48 h in an orbital shaker at 200 rpm. 

Phrase: "Preparation of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: ")"

Phrase: "FibrilsHuman A-(140"

Phrase: ")-"

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Batch number MK0611 from California Peptide Research,"

Phrase: "Napa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417599:NAPA [Gene or Genome]
  1000   C1538038:NAPA [Gene or Genome]

Phrase: "CA)"

Phrase: "was"

Phrase: "incubated at 0.5 mg/ml"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C2984062:mg/5 ml [Quantitative Concept]
   790   C0439294:mg ml [Quantitative Concept]
   790   C0444499:0/5 [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in PB buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10 mM sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 37 C"

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in an orbital shaker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0687735:Shaker [Population Group]

Phrase: "at 200 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.66: The formation of fibrils was confirmed by Congo Red binding (21) and Thio T binding (21) together with analysis by negative stain electron microscopy using 1% phosphotungstic acid. 

Phrase: "The formation of fibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "confirmed by Congo Red binding"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0009738:Congo [Geographic Area]
   760   C0243122:binding [Functional Concept]
   760   C0332575:Red [Finding]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1260956:Red [Qualitative Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "(21"

Phrase: ")"

Phrase: "and"

Phrase: "Thio T binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(21"

Phrase: ")"

Phrase: "together with analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "by negative stain electron microscopy"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C1441647:Electron microscopy, negative stain [Laboratory Procedure]
   861   C0026019:Electron Microscopy [Laboratory Procedure]
   861   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   812   C0013852:Electron [Quantitative Concept]
   812   C0026018:Microscopy [Laboratory Procedure]
   812   C3463986:Electron [Bird]
   741 E C0013850:Electronic [Manufactured Object]
   741 E C0205288:Microscopic [Qualitative Concept]
   741 E C1547561:Electronic [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1% phosphotungstic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0031730:Phosphotungstic Acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.67: Fibrils were used immediately upon production or aliquoted and stored at 80 C. 

Phrase: "Fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immediately upon production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033268:production [Occupational Activity]
   790   C0205548:Immediately [Temporal Concept]

Phrase: "or"

Phrase: "aliquoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "and"

Phrase: "stored at 80 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]
Processing 00000000.tx.68: No difference in ligand binding behavior was observed between freshly prepared and frozen material as noted also by others (7). 

Phrase: "No difference in ligand binding behavior"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "observed between freshly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "frozen material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "as"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "also by others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1955473:Others [Finding]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.69: Compound PreparationAll compounds were prepared as 110 mM Me2SO stocks before dilution into assay buffer. 

Phrase: "Compound PreparationAll compounds"

Phrase: "were"

Phrase: "prepared as 110 mM Me2SO stocks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521827:Prepare [Functional Concept]
   719   C1710198:Stock [Idea or Concept]

Phrase: "before dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "into assay buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.70: The maximum final concentration of Me2SO in the assays was 0.5%. 

Phrase: "The maximum final concentration of Me2SO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2347813:Concentration Maximum [Quantitative Concept]
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "in the assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "0.5%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]
Processing 00000000.tx.71: Because of the relatively low solubility of the ligands (with the exception of Thio T) in aqueous solution, all assays were performed in PB supplemented with 10% ethanol (PBE) and at a maximum concentration of 5 M compound. 

Phrase: "Because of the relatively low solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037628:Solubility [Qualitative Concept]
   755 E C1749467:soluble [Cell Component]
   755 E C1948047:Soluble [Qualitative Concept]

Phrase: "of the ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "("

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of Thio T)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332285:Of [Spatial Concept]
   827   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in aqueous solution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3255993:aqueous solution [Pharmacologic Substance]
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
   861   C0599956:Aqueous [Qualitative Concept]

Phrase: "all assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in PB"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "supplemented with 10% ethanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001962:Ethanol [Organic Chemical]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "(PBE"

Phrase: ")"

Phrase: "and at a maximum concentration of 5 M compound."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C2347813:Maximum Concentration [Quantitative Concept]
   762   C1440942:M-5 [Immunologic Factor]
   742   C0086045:Concentration [Mental Process]
   742   C0205198:Compound [Qualitative Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C0806909:Maximum [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1515981:And [Idea or Concept]
   742   C1552615:maximum [Quantitative Concept]
   742   C1706082:Compound [Chemical]
   742   C2826546:MAXIMUM [Quantitative Concept]
Processing 00000000.tx.72: Intrinsic Fluorescence Binding AssaysIntrinsic fluorescence intensity (FLINT) changes associated with ligand binding to A-(140) were recorded in a Ultra Evolution 384 plate reader (Tecan, Reading, UK) using a 340440-nm filter pair. 

Phrase: "Intrinsic Fluorescence Binding AssaysIntrinsic fluorescence intensity (FLINT) changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0392747:changes [Functional Concept]
   795   C0443172:changes [Quantitative Concept]
   785   C0428760:Intensity change [Laboratory or Test Result]
   762 E C1705241:Change [Quantitative Concept]

Phrase: "associated with ligand binding"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1517880:Ligand Binding [Molecular Function]
   770   C0023688:Ligand [Chemical]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to A-(140"

Phrase: ")"

Phrase: "were"

Phrase: "recorded in a Ultra Evolution 384 plate reader"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0005971:Plate [Medical Device]
   744   C0015219:Evolution [Genetic Function]
   744   C0728475:ultra [Medical Device]
   744   C1139930:plate [Medical Device]
   744   C1514743:Reader [Professional or Occupational Group]
   744   C1706461:Reader [Manufactured Object]
   744   C3537155:Plate [Manufactured Object]
   711   C0034869:Record [Intellectual Product]

Phrase: "(Tecan,"

Phrase: "Reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: ","

Phrase: "UK"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 340440-nm filter pair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.73: For assays measuring the binding of Thio T, a 450505-nm filter pair was used. 

Phrase: "For assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the binding of Thio T,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "a 450505-nm filter pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.74: Two formats were used for the FLINT assays. 

Phrase: "Two formats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301627:formats [Intellectual Product]

Phrase: "were"

Phrase: "used for the FLINT assays."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0522510:Intensity [Qualitative Concept]
   753   C1273517:used [Finding]
   719   C0005507:Assay [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719   C0243073:assay [Qualitative Concept]
   719 E C0457083:Use [Functional Concept]
   719   C1510438:Assay [Laboratory Procedure]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.75: FLINT1 was performed using a fixed concentration of ligand (50 or 100 nM) and varying concentrations of A-(140) polymer. 

Phrase: "FLINT1"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fixed concentration of ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(50"

Phrase: "or"

Phrase: "100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "varying concentrations of A-(140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "polymer."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]
Processing 00000000.tx.76: FLINT2 was performed using a fixed concentration of A-(140) (500 nM) and varying concentrations of ligand (0 to 2 M) as detailed under "Results." 

Phrase: "FLINT2"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fixed concentration of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "(500 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "varying concentrations of ligand"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(0 to 2"

Phrase: "M)"

Phrase: "as"

Phrase: "detailed under ""Results."""
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1522508:Detailed [Qualitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756 E C1561567:detail [Functional Concept]
   756   C2825142:Result [Finding]
Processing 00000000.tx.77: Fluorescence polarization measurements were recorded in a Ultra Evolution 384 plate reader using a 360-nm polarizing excitation filter and 440-nm emission filters. 

Phrase: "Fluorescence polarization measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:measurements [Functional Concept]
   734   C0016316:Fluorescence Polarization [Laboratory Procedure]

Phrase: "were"

Phrase: "recorded in a Ultra Evolution 384 plate reader"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0005971:Plate [Medical Device]
   744   C0015219:Evolution [Genetic Function]
   744   C0728475:ultra [Medical Device]
   744   C1139930:plate [Medical Device]
   744   C1514743:Reader [Professional or Occupational Group]
   744   C1706461:Reader [Manufactured Object]
   744   C3537155:Plate [Manufactured Object]
   711   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 360-nm polarizing excitation filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0180860:Filter [Manufactured Object]
   804   C0581406:Filter [Medical Device]
   804   C1522664:Filter [Intellectual Product]
   804   C1704449:Filter [Conceptual Entity]
   804   C1704684:Filter [Medical Device]
   804   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "440-nm emission filters."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0180860:Filters [Manufactured Object]
   779 E C0581406:Filter [Medical Device]
   779 E C1522664:Filter [Intellectual Product]
   779 E C1704449:Filter [Conceptual Entity]
   779 E C1704684:Filter [Medical Device]
   779 E C1875155:FILTER [Medical Device]
Processing 00000000.tx.78: The assays employed a fixed concentration of BTA-1 (50 nM) and varying concentrations of A-(140) (050 M). 

Phrase: "The assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a fixed concentration of BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(50 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "varying concentrations of A-(140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "(050"

Phrase: "M)."
Processing 00000000.tx.79: All fluorescent assays were performed in PBE in a final volume of 80 l and were incubated for 2 h at 20 C before reading. 

Phrase: "All fluorescent assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in PBE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 80 l"

Phrase: "and"

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 20 C"

Phrase: "before reading."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]
Processing 00000000.tx.80: All data points were performed at least in quadruplicate and were analyzed using Grafit (Erithacus Software Limited, Horley, UK) to obtain Kd values using the single site ligand-binding module. 

Phrase: "All data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "performed at least"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in quadruplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205175:Quadruplicate [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Grafit"

Phrase: "(Erithacus Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "Limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: ","

Phrase: "Horley,"

Phrase: "UK"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Kd values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0026691:KD [Disease or Syndrome]
   861   C0042295:Values [Qualitative Concept]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the single site ligand-binding module."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1709061:Module [Conceptual Entity]
   704 E C1031041:Modulus [Eukaryote]
Processing 00000000.tx.81: Fluorescence Competition Assays (FLINT3)Competition assays employed a fixed concentration of A-(140) (2 M) and Thio T (1 M) and used varying concentration ranges of competitor ligands (up to 4 M). 

Phrase: "Fluorescence Competition Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "(FLINT3"

Phrase: ")"

Phrase: "Competition assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a fixed concentration of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: "and"

Phrase: "Thio T (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "M)"

Phrase: "and"

Phrase: "used varying concentration ranges of competitor ligands"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1514721:*Ranges [Quantitative Concept]
   714 E C2348147:Range [Quantitative Concept]
   714 E C3542016:Range [Intellectual Product]

Phrase: "("

Phrase: "up to 4"

Phrase: "M)."
Processing 00000000.tx.82: Reactions were performed in PBE in a final volume of 80 l and were incubated for 2 h at 20 C before measurement in a Ultra Evolution 384 plate reader using a 450505-nm filter pair. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed in PBE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 80 l"

Phrase: "and"

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 20 C"

Phrase: "before measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "in a Ultra Evolution 384 plate reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514743:Reader [Professional or Occupational Group]
   804   C1706461:Reader [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 450505-nm filter pair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.83: All data points were performed in quadruplicate, and the fluorescent signal in the absence of competitor defined a fractional binding of 1. 

Phrase: "All data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "performed in quadruplicate,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205175:Quadruplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "the fluorescent signal in the absence of competitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "a fractional binding of 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.84: Data were analyzed using Grafit to obtain IC50 values using full 4-parameter curve fits. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Grafit to"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "IC50 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "full 4-parameter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0549193:Parameter [Spatial Concept]
   827   C1704769:Parameter [Conceptual Entity]
   827   C2350001:Parameter [Quantitative Concept]

Phrase: "curve fits."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0036572:Fits NOS [Sign or Symptom]
   861   C0205134:Curve [Spatial Concept]
   827 E C0424576:Fit [Finding]
   827 E C2349186:Fit [Activity]
Processing 00000000.tx.85: Ki values were derived from the Cheng-Prusoff equation (22), Ki = IC50/(1 + ([L]/Kd)) were [L] was the concentration (1000 nM) and Kd (750 nM) of Thio T used in the assay. 

Phrase: "Ki values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "derived from the Cheng-Prusoff equation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0552449:Equation [Conceptual Entity]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "Ki = IC50/(1 +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600495:IC50 [Quantitative Concept]

Phrase: "("

Phrase: "[L]/Kd))"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "were"

Phrase: "[L]"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "was"

Phrase: "the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(1000 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "Kd (750 nM) of Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]

Phrase: "used in the assay."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.86: Fluorescence Energy Transfer (FRET) MeasurementsFRET assays employed fixed concentrations of A-(140) (2 M) and Thio T (1 M) and either 100 nM BF1 or 100 nM BTA-1 in PBE. 

Phrase: "Fluorescence Energy Transfer (FRET) MeasurementsFRET assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "fixed concentrations of A-(140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: "and"

Phrase: "Thio T (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "M)"

Phrase: "and"

Phrase: "either 100 nM BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0812297:BF1 [Gene or Genome]
   812   C1705148:BF1 [Gene or Genome]

Phrase: "or"

Phrase: "100 nM BTA-1 in PBE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0053246:benzothiazole [Organic Chemical]
   760   C3536937:Benzothiazole [Pharmacologic Substance]
Processing 00000000.tx.87: Measurements were performed in a RF-5301PC spectrofluorimeter (Shimadzu Europa, Milton Keynes, UK) running Hyper RF software. 

Phrase: "Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed in a RF-5301PC spectrofluorimeter"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0201660:RF [Laboratory Procedure]
   753   C0748398:RF [Finding]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Shimadzu Europa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242751:Europa [Geographic Area]

Phrase: "Milton Keynes,"

Phrase: "UK"

Phrase: ")"

Phrase: "running Hyper RF software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.88: Emission spectra (400550 nm) were collected following excitation at 340 nm using excitation and emission slit widths of 5 and 1.5 nm, respectively. 

Phrase: "Emission spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0233929:Emission [Body Substance]
   861   C2349995:Emission [Substance]
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "(400550 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "excitation at 340 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549255:Excitation [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission slit widths of 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0487742:Width [Quantitative Concept]

Phrase: "and"

Phrase: "1.5 nm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0312860:NM [Cell Function]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.89: Radioligand Binding AssaysA fixed concentration of A-(140) (40 nM) was titrated against a range of [3H]Me-BTA-1 concentrations (0.0540 nM) in PB buffer supplemented with 10% ethanol (PBE) for 3 h at 20 C. 

Phrase: "Radioligand Binding AssaysA"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "concentration of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "(40 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "titrated against a range of [3H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1442460:3H [Temporal Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]
   719   C1883350:Titrate [Health Care Activity]

Phrase: "]Me-BTA-1 concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(0.0540 nM) in PB buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]

Phrase: "supplemented with 10% ethanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001962:Ethanol [Organic Chemical]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "(PBE"

Phrase: ")"

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 20 C."
Processing 00000000.tx.90: The final reaction volume was 500 l. 

Phrase: "The final reaction volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "500 l."
Processing 00000000.tx.91: Nonspecific binding was determined in the presence of 50 M Thio T. 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "determined in the presence of 50 M Thio T."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0441923:M+ [Intellectual Product]
   742   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.92: The bound and free fractions were separated by vacuum filtration through GF/B glass filters (Whatman, Maidstone, UK) using an M-48T harvester (Brandel, Gaithersburg, MD) followed by four 1-ml washes with PBE. 

Phrase: "The bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "free fractions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C0522531:free fraction [Spatial Concept]
   861   C0332296:free [Functional Concept]
   861   C1264633:Fractions [Quantitative Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "separated by vacuum filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016107:filtration [Laboratory Procedure]
   770   C0042221:Vacuum [Natural Phenomenon or Process]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]

Phrase: "through GF/B glass filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0180860:Filters [Manufactured Object]
   779 E C0581406:Filter [Medical Device]
   779 E C1522664:Filter [Intellectual Product]
   779 E C1704449:Filter [Conceptual Entity]
   779 E C1704684:Filter [Medical Device]
   779 E C1875155:FILTER [Medical Device]

Phrase: "(Whatman,"

Phrase: "Maidstone,"

Phrase: "UK"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an"

Phrase: "M-"

Phrase: "48T harvester"

Phrase: "(Brandel,"

Phrase: "Gaithersburg,"

Phrase: "MD)"

Phrase: "followed by four 1-ml washes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0205450:Four [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   719   C0441648:Wash [Activity]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with PBE."
Processing 00000000.tx.93: Filters containing the bound ligand were mixed with 3 ml of Ultima Gold MV scintillation liquid (PerkinElmer Life Sciences) and incubated for 2 h before counting in a TriCarb 2100TR liquid scintillation counter (PerkinElmer Life Sciences). 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the bound ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "were"

Phrase: "mixed with 3 ml of Ultima Gold MV scintillation liquid"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   739   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0205430:Mixed [Functional Concept]
   739   C0302908:Liquid [Substance]
   739   C0439526:/mL [Quantitative Concept]
   739   C0678573:scintillation [Natural Phenomenon or Process]
   739   C1304698:Liquid [Finding]
   739   C1304897:Gold [Functional Concept]
   739   C1546699:Liquid NOS [Intellectual Product]
   739   C1561501:Liquid NOS [Substance]
   739   C3160715:Mixed [Finding]
   706 E C1421951:MIX [Gene or Genome]
   706 E C1720722:Mix [Qualitative Concept]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "before counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "in a TriCarb 2100TR liquid scintillation counter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0036405:Scintillation Counter [Medical Device]
   840   C1710025:Scintillation Counter [Manufactured Object]
   804   C0677601:Counter [Manufactured Object]
   804   C0678573:scintillation [Natural Phenomenon or Process]
   804   C1705206:Counter [Medical Device]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.94: All data points were performed in triplicate. 

Phrase: "All data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.95: The specific binding signal under these assay conditions was 70%. 

Phrase: "The specific binding signal under these assay conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "70%."
Processing 00000000.tx.96: Data were analyzed using Grafit to obtain the apparent dissociation constant (Kd) and the maximal number of binding sites (Bmax) using the single site ligand-binding module. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Grafit to"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the apparent dissociation constant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "and"

Phrase: "the maximal number of binding sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0445108:Number of sites [Quantitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "(Bmax)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the single site ligand-binding module."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1709061:Module [Conceptual Entity]
   704 E C1031041:Modulus [Eukaryote]
Processing 00000000.tx.97: Radioligand Competition AssaysCompetition assays employed a fixed concentration of A-(140) (40 nM) and [3H]Me-BTA-1 (4 nM) and used varying concentration ranges of cold competitor dependent on the ligand. 

Phrase: "Radioligand Competition AssaysCompetition assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0034596:Radioligand Assays [Laboratory Procedure]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a fixed concentration of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "(40 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(4 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "used varying concentration ranges of cold competitor"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1514721:*Ranges [Quantitative Concept]
   714 E C2348147:Range [Quantitative Concept]
   714 E C3542016:Range [Intellectual Product]

Phrase: "dependent on the ligand."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]
Processing 00000000.tx.98: Reactions were performed in PBE and were incubated for 2 h at 20 C before harvesting and counting as described above. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed in PBE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 20 C"

Phrase: "before harvesting"

Phrase: "and"

Phrase: "counting as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.99: Nonspecific binding was determined in the presence of 50 M Thio T. 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "determined in the presence of 50 M Thio T."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0441923:M+ [Intellectual Product]
   742   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.100: BF1 (200 nM) was used to determine nonspecific binding for assays involving Thio T. 

Phrase: "BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "(200 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "nonspecific binding for assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205370:Non-specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C0750540:Nonspecific [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "Thio T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.101: All data points were performed in triplicate, and the specific binding signal in the absence of competitor defined a fractional binding of 1. 

Phrase: "All data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "performed in triplicate,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "the specific binding signal in the absence of competitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "a fractional binding of 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.102: Data were analyzed using Grafit to obtain IC50 values using full 4-parameter curve fits. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Grafit to"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "IC50 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "full 4-parameter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0549193:Parameter [Spatial Concept]
   827   C1704769:Parameter [Conceptual Entity]
   827   C2350001:Parameter [Quantitative Concept]

Phrase: "curve fits."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0036572:Fits NOS [Sign or Symptom]
   861   C0205134:Curve [Spatial Concept]
   827 E C0424576:Fit [Finding]
   827 E C2349186:Fit [Activity]
Processing 00000000.tx.103: Ki values were derived as stated above using the Cheng-Prusoff equation (22), where [L] was the concentration (4 nM) and Kd (4.2 nM) of the radioligand used in the assays. 

Phrase: "Ki values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "derived as stated above"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1301808:stated [Geographic Area]
   770   C1441547:Derived [Qualitative Concept]
   770   C1442792:Stated [Functional Concept]
   770   C3245521:derived [Idea or Concept]
   737 E C3148680:State [Geographic Area]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cheng-Prusoff equation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0552449:Equation [Conceptual Entity]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "where"

Phrase: "[L]"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "was"

Phrase: "the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(4 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "Kd (4.2 nM) of the radioligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0312860:NM [Cell Function]

Phrase: "used in the assays."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1273517:used [Finding]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737   C0243073:assay [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.104: Density Gradient Centrifugation of A FibrilsA fibril preparations were fractionated on gradients consisting of 700 l each of 60, 50, 40, 30, 20, 10, and 280 l of 5% Optiprep (Sigma) prepared in 13 x 51-mm ultraclear centrifuge tubes (Beckman Instruments, High Wycombe, UK). 

Phrase: "Density Gradient Centrifugation of A FibrilsA fibril preparations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   744   C0007703:Centrifugation [Laboratory Procedure]
   744   C0178587:density [Quantitative Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "were"

Phrase: "fractionated on gradients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0812409:gradients [Quantitative Concept]
   790   C1979893:Fractionated [Qualitative Concept]
   756 E C0439182:% gradient [Quantitative Concept]

Phrase: "consisting of 700 l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "each of 60,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "50,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "30,"

Phrase: "20,"

Phrase: "10,"

Phrase: "and"

Phrase: "280 l of 5% Optiprep"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "prepared in 13 x 51-mm ultraclear centrifuge tubes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0175730:tubes [Medical Device]
   742   C0179834:centrifuge [Medical Device]
   742   C1547937:Tubes [Intellectual Product]
   742   C1704474:Tubes [Quantitative Concept]
   708   C1521827:Prepare [Functional Concept]
   708 E C1561954:tube [Conceptual Entity]
   708 E C1704730:TUBE [Medical Device]

Phrase: "(Beckman Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "High Wycombe,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.105: A 300-l sample of A fibrils (0.5 mg/ml) in PB was carefully layered on top of the Optiprep gradient and then fractionated at 50,000 rpm for 2 h and 30 min at 22 C in an Optima Max-E ultracentrifuge using an MLS-50 swinging bucket rotor (Beckman Instruments). 

Phrase: "A 300-l sample of A fibrils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "(0.5 mg/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "ml) in PB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "carefully"

Phrase: "layered on top of the Optiprep gradient"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C0934502:Layered [Body Part, Organ, or Organ Component]
   748   C1704458:Top [Spatial Concept]
   748   C3642362:OptiPrep [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   714 E C1522408:Layer [Qualitative Concept]
   714 E C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fractionated at 50,000 rpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0582523:rpm [Quantitative Concept]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "30 min at 22 C in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]

Phrase: "an Optima Max-E ultracentrifuge"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an MLS-50 swinging bucket rotor"

Phrase: "(Beckman Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")."
Processing 00000000.tx.106: Following centrifugation, the bottoms of the tubes were pierced with a 21-gauge syringe needle, and 12 x 400-l fractions were collected for analysis. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the bottoms of the tubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1511276:Bottom [Spatial Concept]
   726   C1552825:bottom [Idea or Concept]

Phrase: "were"

Phrase: "pierced with a 21-gauge syringe needle,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1875815:syringe needle [Medical Device]
   774   C3640175:Needle Gauge [Quantitative Concept]
   748   C0027551:Needle [Medical Device]
   748   C0039142:Syringe [Medical Device]
   748   C0456564:Gauge [Spatial Concept]
   748   C0935563:pierced [Therapeutic or Preventive Procedure]
   748   C1521879:GAGE [Immunologic Factor]
   748   C1704318:Needle [Medical Device]
   748   C1706072:Syringe [Manufactured Object]
   748   C1882041:Needle [Spatial Concept]

Phrase: "and"

Phrase: "12 x 400-l fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected for analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.107: Fraction 1 represents the most dense part of the gradient and fraction 12 the least dense part of the gradient. 

Phrase: "Fraction 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the most dense part of the gradient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "fraction 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "the least dense part of the gradient."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.108: The fractions were analyzed for thioflavin T binding by mixing 80 l of each fraction with 2 l of 100 M thioflavin and reading the fluorescence after 2 h of incubation in an Ultra Evolution 384 plate reader using a 450505-nm filter pair. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed for thioflavin T binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0243122:binding [Functional Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "by mixing 80 l"

Phrase: "of each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "with 2 l"

Phrase: "of 100 M thioflavin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "the fluorescence after 2 h of incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "in an Ultra Evolution 384 plate reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514743:Reader [Professional or Occupational Group]
   804   C1706461:Reader [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 450505-nm filter pair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.109: In addition, 5 l of each fraction was separated by SDS-PAGE followed by blotting onto nitrocellulose as described previously (23). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "5 l of each fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C2348935:.5 L [Quantitative Concept]

Phrase: "was"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "followed by blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "onto nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   916 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.110: Blots were probed with the mouse anti-human -amyloid antibody 6E10 (Merck) at a 1:1000 dilution followed by an anti-mouse horseradish peroxidase-conjugated antibody (Sigma) at a 1:10,000 and were then developed with SuperSignal West Dura extended duration substrate (Perbio, Cheshire, UK). 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with the mouse anti-human -amyloid antibody 6E10"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   801   C1291910:Human anti-mouse antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   801   C1295018:Human Anti-Mouse Antibody [Laboratory Procedure]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0086418:Human [Human]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0182400:Probe [Medical Device]
   708   C1704681:Probe [Gene or Genome]
   708   C2347609:Probe [Chemical Viewed Functionally]
   708   C3536729:Probe [Manufactured Object]

Phrase: "(Merck"

Phrase: ")"

Phrase: "at a 1"

Phrase: ":"

Phrase: "1000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "followed by an anti-mouse horseradish peroxidase-conjugated antibody"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   764   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   764   C0332283:Followed by [Temporal Concept]
           followed
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0330510:Horseradish [Food]
   742   C0522529:Conjugated [Spatial Concept]
   742   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   742   C1110641:Horseradish [Plant]
   742   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "at a 1"

Phrase: ":"

Phrase: "10,000"

Phrase: "and"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "developed with SuperSignal West Dura"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0013313:Dura [Body Part, Organ, or Organ Component]
   760   C1705493:West [Spatial Concept]

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "duration substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "(Perbio,"

Phrase: "Cheshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454844:Cheshire [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.111: Images of the blot were captured using a Chemigenius2 imaging system (Syngene, Cambridge, UK) and quantified using Genetools (Syngene). 

Phrase: "Images of the blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Chemigenius2 imaging system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2697665:Imaging System [Manufactured Object]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Syngene,"

Phrase: "Cambridge,"

Phrase: "UK"

Phrase: ")"

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Genetools"

Phrase: "(Syngene"

Phrase: ")."
Processing 00000000.tx.112: Radioligand binding was evaluated by mixing 50 l of each fraction with 450 l of 4 nM [3H]Me-BTA-1 prepared in PBE. 

Phrase: "Radioligand binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "evaluated by mixing 50 l of each fraction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   767   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C0205430:mixing [Functional Concept]
   744   C0220825:Evaluated [Functional Concept]
   744   C1554103:Fraction [Idea or Concept]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]

Phrase: "with 450 l"

Phrase: "of 4 nM [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "prepared in PBE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.113: The reactions were incubated for 2 h at 20 C before harvesting and counting as described above by vacuum filtration.  

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 20 C"

Phrase: "before harvesting"

Phrase: "and"

Phrase: "counting as described above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "by vacuum filtration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016107:filtration [Laboratory Procedure]
Processing 00000000.tx.114: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Determination of Binding Constants Using Fluorescence AssaysThe compounds used in this study (Fig. 1) all share similar fluorescent properties, with excitation and emission wavelengths of around 340 and 440 nm, respectively, but that are distinct from those of Thio T (450:480 nm) (data not shown). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Determination of Binding Constants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fluorescence AssaysThe compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "all"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "similar fluorescent properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "with excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449819:wavelengths [Quantitative Concept]

Phrase: "around 340"

Phrase: "and"

Phrase: "440 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively,"

Phrase: "but"

Phrase: "that"

Phrase: "are"

Phrase: "distinct from those of Thio T (450"

Phrase: ":"

Phrase: "480 nm) (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: In addition, the compounds display increases in their intrinsic FLINT when bound to A-(140) fibrils along with slight shifts in their excitation and emission wavelengths consistent with ligand binding into a hydrophobic pocket on the fibrils. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "increases in their intrinsic FLINT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "when"

Phrase: "bound to A-(140"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: ")"

Phrase: "fibrils along with slight shifts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0225328:fibrils [Cell Component]
   726 E C1948066:Fibril [Physical Object]

Phrase: "in their excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:wavelengths [Quantitative Concept]

Phrase: "consistent with ligand binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "into a hydrophobic pocket"

Phrase: "on the fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.116: The exception to this was BTA-1, which displayed a slight decrease (510%) in FLINT when bound to the A-(140) fibrils. 

Phrase: "The exception to this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1554961:exception [Idea or Concept]
   770   C1705847:Exception [Conceptual Entity]

Phrase: "was"

Phrase: "BTA-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "which"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a slight decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "(510%"

Phrase: ")"

Phrase: "in FLINT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "when"

Phrase: "bound to the A-(140"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: ")"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.117: The increases in FLINT upon ligand binding to A-(140) fibrils were exploited in designing simple, homogeneous assays to directly measure compound binding. 

Phrase: "The increases in FLINT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "upon ligand binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517880:Ligand Binding [Molecular Function]
   861   C0023688:Ligand [Chemical]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "exploited in designing simple, homogeneous assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205352:Simple [Qualitative Concept]
   753   C1881065:Homogeneous [Qualitative Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "compound binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.118: Two assay formats were employed, FLINT1 and FLINT2. 

Phrase: "Two assay formats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1301627:formats [Intellectual Product]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: ","

Phrase: "FLINT1"

Phrase: "and"

Phrase: "FLINT2."
Processing 00000000.tx.119: In FLINT1 assays, compound binding was measured by using a fixed concentration of ligand (50 or 100 nM) and varying concentrations of A-(140) polymer (Fig. 2, A and C). 

Phrase: "In FLINT1 assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "compound binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fixed concentration of ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(50"

Phrase: "or"

Phrase: "100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "varying concentrations of A-(140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.120: A fixed concentration of A-(140) polymer (500 nM) and varying concentrations of ligand were used in the FLINT2 assays (Fig. 2, B and D). 

Phrase: "A fixed concentration of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "(500 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "varying concentrations of ligand"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "used in the FLINT2 assays"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C1273517:used [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.121: The binding constants Kd1 and Kd2 obtained from the FLINT1 and FLINT2 assays are summarized in Table I. 

Phrase: "The binding constants Kd1"

Phrase: "and"

Phrase: "Kd2"

Phrase: "obtained from the FLINT1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "FLINT2 assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "are"

Phrase: "summarized in Table I."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.122: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.124: Fluorescence ligand binding assays. 

Phrase: "Fluorescence ligand binding assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.125: A and C are shown in FLINT1 assay format; 

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "are"

Phrase: "shown in FLINT1 assay format"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1301627:Format [Intellectual Product]
   760   C1510438:Assay [Laboratory Procedure]
   726   C1547282:Show [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.126: B and D are in FLINT2 assay format; 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "are in FLINT2 assay format"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1301627:Format [Intellectual Product]
   760   C1510438:Assay [Laboratory Procedure]
   760   C1551058:Are [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.127: and E is a fluorescence anisotropy assay. 

Phrase: "and"

Phrase: "E"

Phrase: "is"

Phrase: "a fluorescence anisotropy assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0085813:Anisotropy, Fluorescence [Natural Phenomenon or Process]
Processing 00000000.tx.128: Representative binding isotherms for Thio T (A and B), BF1 (C and D), and BTA-1 (E) are shown.  

Phrase: "Representative binding isotherms for Thio T (A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "(C"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: "BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(E)"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.129: View this table: [in this window] [in a new window]  TABLE I Summary of fluorescent and radioligand (RL) binding data Kd values are shown in boldface. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Summary of fluorescent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552616:summary [Intellectual Product]
   760   C1706244:Summary [Intellectual Product]

Phrase: "and"

Phrase: "radioligand (RL) binding data Kd values"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   836   C1704610:Data Value [Intellectual Product]
   804   C0026691:KD [Disease or Syndrome]
   804   C0042295:Values [Qualitative Concept]
   804   C1705240:KD [Gene or Genome]
   804   C1839259:KD [Disease or Syndrome]
   771 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shown in boldface."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.130: The Ki values for both IMPY derivatives in the Thio T competition assay have not been calculated due to their limited solubility in aqueous solution resulting in incomplete displacement curves. 

Phrase: "The Ki values for both IMPY derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "in the Thio T competition assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "calculated due to their limited solubility"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0037628:Solubility [Qualitative Concept]
   753   C0439801:Limited [Functional Concept]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C3146286:Due [Idea or Concept]
   753   C3542948:Limited [Intellectual Product]

Phrase: "in aqueous solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3255993:aqueous solution [Pharmacologic Substance]
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
   861   C0599956:Aqueous [Qualitative Concept]

Phrase: "resulting in incomplete displacement curves."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0332294:Resulting in [Functional Concept]
   760   C0012725:Displacement [Mental Process]
   760   C0012727:Displacement [Spatial Concept]
   760   C0205257:Incomplete [Quantitative Concept]
   760   C0456080:Displacement [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C0728938:incomplete [Quantitative Concept]
   760   C1548386:incomplete [Idea or Concept]
   760   C2347509:Displacement [Phenomenon or Process]
   726   C0205134:Curve [Spatial Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.131: RLA, radioligand assay using [3H]Me-BTA-1. 

Phrase: "RLA,"

Phrase: "radioligand assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034596:Radioligand Assay [Laboratory Procedure]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]
Processing 00000000.tx.132: Literature values are shown for comparison in the last column. 

Phrase: "Literature values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0023866:Literature [Intellectual Product]
   861   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shown for comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Comparison [Activity]
   756   C1547282:Show [Intellectual Product]

Phrase: "in the last column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.133: ND, not determined; 

Phrase: "ND,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "determined"

Phrase: ";"
Processing 00000000.tx.134: NA, not applicable.  

Phrase: "NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1272460:{NA} [Qualitative Concept]

Phrase: "not applicable."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1272460:Not Applicable [Qualitative Concept]
           applicable
   861   C1706839:Applicable [Qualitative Concept]
Processing 00000000.tx.135: The binding of BTA-1 to A-(140) fibrils was determined by fluorescent anisotropy measurements using a fixed concentration of ligand (50 nM) and varying concentrations of polymer (Fig. 2E). 

Phrase: "The binding of BTA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "was"

Phrase: "determined by fluorescent anisotropy measurements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085406:Anisotropy [Natural Phenomenon or Process]
   760   C0242485:measurements [Functional Concept]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fixed concentration of ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(50 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "varying concentrations of polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.136: The apparent Kd value from this assay was 5.23 M. 

Phrase: "The apparent Kd value from this assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0026691:KD [Disease or Syndrome]
   748   C1522609:Value [Quantitative Concept]
   748   C1705240:KD [Gene or Genome]
   748   C1839259:KD [Disease or Syndrome]

Phrase: "was"

Phrase: "5.23 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.137: The anisotropy value of the compound at saturating concentrations of polymer was 0.4, which is toward the maximum limit for a fluorophore (24) and probably reflects the large Stokes radii of the A-(140) polymers. 

Phrase: "The anisotropy value of the compound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "at saturating concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "was"

Phrase: "0.4,"

Phrase: "which"

Phrase: "is toward the maximum limit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0439801:limit [Functional Concept]
   760   C0806909:Maximum [Quantitative Concept]
   760   C1549649:Limit [Idea or Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2349209:Limit [Conceptual Entity]
   760   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "for a fluorophore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598447:fluorophore [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the large Stokes radii of the A-(140"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0034627:Radius [Body Part, Organ, or Organ Component]
   711   C1279083:Radius [Body Part, Organ, or Organ Component]
   711   C1306504:Radius [Quantitative Concept]

Phrase: ")"

Phrase: "polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]
Processing 00000000.tx.138: The binding isotherms for all of the ligands in all assay formats were consistent with a single population of binding sites for each of the ligands. 

Phrase: "The binding isotherms for all of the ligands"

Phrase: "in all assay formats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1301627:formats [Intellectual Product]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "consistent with a single population of binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for each"

Phrase: "of the ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]
Processing 00000000.tx.139: The apparent Kd values from the assays were found to be strongly dependent on the assay format, with the FLINT2 assays consistently reporting lower values. 

Phrase: "The apparent Kd values from the assays"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0026691:KD [Disease or Syndrome]
   748   C0042295:Values [Qualitative Concept]
   748   C1705240:KD [Gene or Genome]
   748   C1839259:KD [Disease or Syndrome]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "strongly dependent on the assay format,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "with the FLINT2 assays consistently reporting lower values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0042295:Values [Qualitative Concept]
   766 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.140: In addition, the rank order of binding constants for the individual compounds was conserved between the two assay formats (Table I). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the rank order of binding constants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0699794:Rank [Intellectual Product]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]

Phrase: "for the individual compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "was"

Phrase: "conserved between the two assay formats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0205448:Two [Quantitative Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C1301627:formats [Intellectual Product]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.141: Comparison of the Kd2 values with the literature values obtained previously indicates that although fluorescence assays are reporting significantly higher values, the rank order of binding affinities is generally well conserved. 

Phrase: "Comparison of the Kd2 values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "with the literature values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0023866:Literature [Intellectual Product]
   861   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "previously"

Phrase: "indicates"

Phrase: "that"

Phrase: "although"

Phrase: "fluorescence assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "are"

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "significantly higher values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "the rank order of binding affinities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0699794:Rank [Intellectual Product]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]

Phrase: "is"

Phrase: "generally well conserved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
Processing 00000000.tx.142: The exception to this was Thio T whose Kd2 value was essentially identical to that reported using a similar assay format by Naiki et al. 

Phrase: "The exception to this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1554961:exception [Idea or Concept]
   770   C1705847:Exception [Conceptual Entity]

Phrase: "was"

Phrase: "Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "whose Kd2 value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "essentially identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a similar assay format by Naiki et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C1301627:Format [Intellectual Product]
   744   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.143: (25) and LeVine (26), indicating that the present set of assays was accurately reporting binding constants. 

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "LeVine"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the present set of assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "was"

Phrase: "accurately"

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "binding constants."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.144: Comparison of Binding Constants Is Consistent with Two Classes of Binding Sites on the A FibrilsThe observation that the binding constants were dependent on assay format was unexpected as both assay formats should report approximately the same Kd values. 

Phrase: "Comparison of Binding Constants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "Is"

Phrase: "Consistent with Two Classes of Binding Sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the"

Phrase: "A FibrilsThe observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the binding constants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "were"

Phrase: "dependent on assay format"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "was"

Phrase: "unexpected as both assay formats"

Phrase: "should"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "approximately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximately [Qualitative Concept]

Phrase: "the same Kd values."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0026691:KD [Disease or Syndrome]
   827   C0042295:Values [Qualitative Concept]
   827   C1705240:KD [Gene or Genome]
   827   C1839259:KD [Disease or Syndrome]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.145: However, an explanation for this difference became apparent when the number of potential binding sites on the A polymer was considered. 

Phrase: "However,"

Phrase: "an explanation for this difference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "became"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "when"

Phrase: "the number of potential binding sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0445108:Number of sites [Quantitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "on the"

Phrase: "A polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "was"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.146: The binding data previously reported with these ligands demonstrated that the binding site density on the A fibrils was <<1 site per A peptide monomer (8, 14). 

Phrase: "The binding data previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "reported with these ligands"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023688:Ligands [Chemical]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the binding site density on the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "was <<"

Phrase: "1 site per A peptide monomer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "(8,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.147: This meant that the effective concentration of binding sites on the fibrils was potentially significantly less than the concentration of A peptide monomers added to the FLINT1 assay. 

Phrase: "This meant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0444504:Mean [Quantitative Concept]
   966   C2347634:Mean [Quantitative Concept]
   966   C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "the effective concentration of binding sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   803   C1373174:Site of concentration [Spatial Concept]
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "on the fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "was"

Phrase: "potentially significantly less than the concentration of A peptide monomers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0086045:Concentration [Mental Process]
   739   C0596973:monomers [Chemical Viewed Structurally]
   739   C1446561:Concentration [Quantitative Concept]

Phrase: "added to the FLINT1 assay."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.148: Because calculation of the Kd1 values are based on the A peptide monomer concentration, this leads to an overestimation of the binding constant by a factor dependent on the binding site density. 

Phrase: "Because"

Phrase: "calculation of the Kd1 values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441506:Calculation [Activity]

Phrase: "are"

Phrase: "based on the"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "A peptide monomer concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "this"

Phrase: "leads to an overestimation of the binding constant"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1547014:*Constant [Quantitative Concept]
   744   C1948059:Constant [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "dependent on the binding site density."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.149: In contrast, the calculation of Kd2 values is directly dependent on the ligand concentration, and as a consequence the FLINT2 assay does not overestimate the binding constants. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the calculation of Kd2 values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441506:Calculation [Activity]

Phrase: "is"

Phrase: "directly dependent on the ligand concentration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and as a consequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "the FLINT2 assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "overestimate"

Phrase: "the binding constants."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.150: Furthermore, the ratio Kd1/Kd2 allows an estimation of the ligand-binding site density on the A-(140) fibrils (Table I). 

Phrase: "Furthermore,"

Phrase: "the ratio Kd1/Kd2"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "an estimation of the ligand-binding site density"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0680844:estimation [Mental Process]
   744   C0681916:Estimation [Quantitative Concept]
   744   C0750572:Estimation [Quantitative Concept]

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.151: This sum clearly splits the ligands into two distinct groups. 

Phrase: "This sum clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515051:Sum [Quantitative Concept]

Phrase: "splits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "the ligands into two distinct groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023688:Ligands [Chemical]
Processing 00000000.tx.152: Thio T, IMPY-H, and IMPY-Me have a ratio of 3040 (i.e. 1 ligand-binding site per 35 A-(140) monomers), whereas TZDM, TZPI, and BF1 have a ratio of 35 (i.e. 1 ligand-binding site per 4 A-(140) monomers). 

Phrase: "Thio T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "IMPY-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "IMPY-H,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "IMPY-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "Me"

Phrase: "have"

Phrase: "a ratio of 3040"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "(i.e. 1 ligand-binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0005456:Binding Site [Receptor]
   827   C0682969:Binding Site [Amino Acid Sequence]
   827   C1517880:Ligand Binding [Molecular Function]
   799   C0023688:Ligand [Chemical]
   799   C0205145:Site [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]

Phrase: "per 35 A-(140"

Phrase: ")"

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "TZDM,"

Phrase: "TZPI,"

Phrase: "and"

Phrase: "BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "have"

Phrase: "a ratio of 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "(i.e. 1 ligand-binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0005456:Binding Site [Receptor]
   827   C0682969:Binding Site [Amino Acid Sequence]
   827   C1517880:Ligand Binding [Molecular Function]
   799   C0023688:Ligand [Chemical]
   799   C0205145:Site [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]

Phrase: "per 4 A-(140"

Phrase: ")"

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")."
Processing 00000000.tx.153: These data suggested that there were at least two distinguishable classes of binding sites on the A fibrils and are supported by the observation that the latter group of compounds all contain a halogen substitute on their aromatic ring. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "were at least two distinguishable classes of binding sites"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0005456:Binding Sites [Receptor]
   745   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0456387:Class [Intellectual Product]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1705943:Class [Classification]
   731 E C0682969:Binding Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "on the"

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "are"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "the latter group of compounds"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "all"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a halogen substitute on their aromatic ring."
Processing 00000000.tx.154: In summary, the data from the intrinsic fluorescence assays are as follows: (a) consistent with a single affinity binding mode for each ligand and accurately reporting intrinsic binding constants; 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the data from the intrinsic fluorescence assays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(a) consistent with a single affinity binding mode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for each ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "and"

Phrase: "accurately"

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "intrinsic binding constants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.155: (b) determining Kd values significantly higher than that previously described; 

Phrase: "(b) determining Kd values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0026691:KD [Disease or Syndrome]
   812   C0042295:Values [Qualitative Concept]
   812   C1705240:KD [Gene or Genome]
   812   C1839259:KD [Disease or Syndrome]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "that previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.156: and (c) when combined with the evidence of the binding site densities and selectivity the data, suggested that there was more than one class of binding site on the A fibrils: a low density site (every 35 A monomers) and a higher density site (every 4 A monomers) that are termed BS1 and BS2, respectively. 

Phrase: "and ("

Phrase: "c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "when"

Phrase: "combined with the evidence of the binding site densities"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   764   C0005456:Binding Site [Receptor]
   764   C0332120:Evidence of [Functional Concept]
           Evidence
   764   C0682969:Binding Site [Amino Acid Sequence]
   762   C1305899:Combined site [Body Location or Region]
   762   C2945843:Site of [Qualitative Concept]
   742   C0178587:densities [Quantitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C0205195:Combined [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "selectivity"

Phrase: "the data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "was"

Phrase: "more than one class of binding site"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   774   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205172:More [Functional Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0456387:Class [Intellectual Product]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C1705943:Class [Classification]
   748   C2825164:Site [Spatial Concept]

Phrase: "on the"

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: ":"

Phrase: "a low density site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "every 35"

Phrase: "A monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "and"

Phrase: "a higher density site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "every 4"

Phrase: "A monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "BS1"

Phrase: "and"

Phrase: "BS2,"

Phrase: "respectively."
Processing 00000000.tx.157: Fluorescent Competition Assays Support Presence of BS1 and BS2Ligand binding to A-(140) fibrils was further characterized by using a fluorescent competition assay (FLINT3) employing Thio T as a reporter for BS1. 

Phrase: "Fluorescent Competition Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "Support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "Presence of BS1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "BS2Ligand binding to A-(140"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterized by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1880022:Characterized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fluorescent competition assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(FLINT3"

Phrase: ")"

Phrase: "employing Thio T as"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "a reporter for BS1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0335038:Reporter [Professional or Occupational Group]
   770   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   770   C1705915:Reporter [Conceptual Entity]
   770   C1709908:Reporter [Group]
Processing 00000000.tx.158: The Ki values obtained from these assays were again significantly higher than those reported in the literature (Table I). 

Phrase: "The Ki values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained from these assays"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1301820:Obtained [Functional Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1706701:Obtain [Activity]

Phrase: "were"

Phrase: "again significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "reported in the literature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.159: However, they were similar to the Kd2 values providing additional evidence that the fluorescent assays were accurately reporting binding data and consistent with our thesis that there were additional ligand-binding sites on the A fibrils. 

Phrase: "However,"

Phrase: "they"

Phrase: "were"

Phrase: "similar to the Kd2 values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the fluorescent assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "accurately"

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "binding data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "consistent with our thesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that there"

Phrase: "were"

Phrase: "additional ligand-binding sites on the"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0005456:Binding Sites [Receptor]
   790   C1517880:Ligand Binding [Molecular Function]
   756 E C0682969:Binding Site [Amino Acid Sequence]
   753   C0023688:Ligand [Chemical]
   753   C0205145:Sites [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "A fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.160: The competitive binding curves were consistent with displacement from a single type of site for each ligand on the fibrils (Fig. 3) and also indicated that the compounds could again be separated into the same two groups identified from the FLINT1/2 assays such that IMPY-H and IMPY-Me (and BTA-1) were able to displace >80% of the bound Thio T (Fig. 3A), whereas TZDM, TZPI, and BF1 were able to displace <50% of the bound Thio T (Fig. 3B). 

Phrase: "The competitive binding curves"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205134:Curve [Spatial Concept]
   734   C0005458:Binding, Competitive [Molecular Function]

Phrase: "were"

Phrase: "consistent with displacement"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "from a single type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "of site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "for each ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "on the fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "also"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "could"

Phrase: "again"

Phrase: "be"

Phrase: "separated into the same two groups"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0086972:Separated [Finding]
   753   C0205448:Two [Quantitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C0687118:Separated [Functional Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "identified from the FLINT1/2 assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "such"

Phrase: "that IMPY-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "IMPY-H"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "IMPY-Me ("

Phrase: "and"

Phrase: "BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0085732:Able [Organism Attribute]
   833   C1299581:Able [Finding]

Phrase: "displace"

Phrase: ">80% of the bound Thio T (Fig. 3A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332297:bound [Spatial Concept]
   744   C0349966:Fig [Food]
   744   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1337208:FIG [Food]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "TZDM,"

Phrase: "TZPI,"

Phrase: "and"

Phrase: "BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0085732:Able [Organism Attribute]
   833   C1299581:Able [Finding]

Phrase: "displace"

Phrase: "<50% of the bound Thio T (Fig. 3B"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332297:bound [Spatial Concept]
   744   C0349966:Fig [Food]
   744   C0450365:3b [Intellectual Product]
   744   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1337208:FIG [Food]
   744   C1689898:% bound [Quantitative Concept]
   744   C1706097:3B [Research Activity]
   744   C2349209:Bound [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.161: Full displacement curves for the IMPY ligands could not be accurately obtained due to compound insolubility at higher concentrations, but it is apparent that they are displacing >50% of the Thio T and that their Ki values are consistent with their Kd2 values. 

Phrase: "Full displacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0012725:Displacement [Mental Process]
   861   C0012727:Displacement [Spatial Concept]
   861   C0456080:Displacement [Qualitative Concept]
   861   C2347509:Displacement [Phenomenon or Process]

Phrase: "curves for the IMPY ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023688:Ligands [Chemical]
   760   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]
   760   C0205134:Curve [Spatial Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "accurately"

Phrase: "obtained due to compound insolubility"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0205198:Compound [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1706082:Compound [Chemical]
   760   C3146286:Due [Idea or Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "at higher concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "displacing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:displacing [Spatial Concept]

Phrase: ">50% of the Thio T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "that"

Phrase: "their Ki values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "consistent with their Kd2 values."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.162: The ability of the ligands TZDM, TZPI, and BF1 to partially displace Thio T may be a consequence of the spatial arrangement of higher density BS2 relative to BS1 on the A fibrils such that they periodically either partially or completely overlap with BS1. 

Phrase: "The ability of the ligands TZDM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "TZPI,"

Phrase: "and"

Phrase: "BF1 to partially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0812297:BF1 [Gene or Genome]
   790   C1705148:BF1 [Gene or Genome]

Phrase: "displace"

Phrase: "Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "may"

Phrase: "be"

Phrase: "a consequence of the spatial arrangement of higher density BS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "relative to BS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "on the"

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "such"

Phrase: "that"

Phrase: "they periodically either partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332182:Periodically [Temporal Concept]

Phrase: "or"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "overlap with BS1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0185027:overlap [Therapeutic or Preventive Procedure]
   790   C1948020:Overlap [Conceptual Entity]
Processing 00000000.tx.163: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.164: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.165: Fluorescent competition assays. 

Phrase: "Fluorescent competition assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.166: Dose-response curves showing the fractional binding of Thio T to A-(140) fibrils in the presence of competitor ligands. 

Phrase: "Dose-response curves"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C0683162:dose-response curve [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   793   C0205134:Curve [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the fractional binding of Thio T"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to A-(140"

Phrase: ")"

Phrase: "fibrils in the presence of competitor ligands."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0225328:fibrils [Cell Component]
   714 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.167: A, , BTA-1; 

Phrase: "A,"

Phrase: ", BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.168: +, IMPY-Me; 

Phrase: "+,"

Phrase: "IMPY-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "Me"

Phrase: ";"
Processing 00000000.tx.169: x, IMPY-H. 

Phrase: "x,"

Phrase: "IMPY-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "IMPY-H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.170: B, , TZDM; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ", TZDM"

Phrase: ";"
Processing 00000000.tx.171: , TZPI; 

Phrase: ", TZPI"

Phrase: ";"
Processing 00000000.tx.172: , BF1.  

Phrase: ", BF1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]
Processing 00000000.tx.173: FRET Measurements Indicate That BS1 and BS2 Are Independent Sites on the A FibrilFurther supporting evidence for the spatial separation but close proximity of BS1 and BS2 was obtained from fluorescent resonance energy transfer (FRET) measurements. 

Phrase: "FRET Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:measurements [Functional Concept]

Phrase: "Indicate"

Phrase: "That BS1"

Phrase: "and"

Phrase: "BS2"

Phrase: "Are"

Phrase: "Independent Sites on the"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "A FibrilFurther supporting evidence for the spatial separation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "but"

Phrase: "close proximity of BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514583:Proximity [Spatial Concept]

Phrase: "and"

Phrase: "BS2"

Phrase: "was"

Phrase: "obtained from fluorescent resonance energy transfer"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0014274:Energy Transfer [Molecular Function]
   753   C0040671:Transfer [Mental Process]
   753   C0231881:Resonance [Finding]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0424589:Energy [Finding]
   753   C0459800:resonance [Natural Phenomenon or Process]
   753   C0542479:Energy [Natural Phenomenon or Process]
   753   C0684213:Resonance [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1442080:Energy [Quantitative Concept]
   753   C1705822:Transfer [Activity]
   737   C0455769:Increased energy [Finding]
   719 E C1706701:Obtain [Activity]

Phrase: "(FRET"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0014274:Energy Transfer [Molecular Function]
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0040671:Transfer [Mental Process]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]
   827   C1705822:Transfer [Activity]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]
Processing 00000000.tx.174: The differing fluorescent properties of BF1 (BS2 probe, excitation/emission maxima 340:440 nm) and Thio T (BS1 probe, excitation/emission maxima 450:480 nm) were again exploited, but this time as a potential donor-acceptor pair. 

Phrase: "The differing fluorescent properties of BF1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "(BS2 probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "excitation/emission maxima 340"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0233929:Emission [Body Substance]
   812   C0549255:Excitation [Activity]
   812   C2349995:Emission [Substance]
   779   C0806909:Maximum [Quantitative Concept]
   779   C1552615:maximum [Quantitative Concept]
   779   C2826546:MAXIMUM [Quantitative Concept]
   729 E C0205289:Maximal [Qualitative Concept]

Phrase: ":"

Phrase: "440 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "Thio T (BS1 probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "excitation/emission maxima 450"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0233929:Emission [Body Substance]
   812   C0549255:Excitation [Activity]
   812   C2349995:Emission [Substance]
   779   C0806909:Maximum [Quantitative Concept]
   779   C1552615:maximum [Quantitative Concept]
   779   C2826546:MAXIMUM [Quantitative Concept]
   729 E C0205289:Maximal [Qualitative Concept]

Phrase: ":"

Phrase: "480 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "again"

Phrase: "exploited"

Phrase: ","

Phrase: "but"

Phrase: "this time as a potential donor-acceptor pair."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040223:Time [Temporal Concept]
   744   C3541383:Time [Temporal Concept]
Processing 00000000.tx.175: By using an excitation wavelength of 340 nm, which specifically excites BF1, the emission spectra of A-(140) fibrils incubated with either Thio T or Thio T/BF1 were recorded. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an excitation wavelength of 340 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449819:Wavelength [Quantitative Concept]

Phrase: "which specifically"

Phrase: "excites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excite [Activity]

Phrase: "BF1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "the emission spectra of A-(140"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0233929:Emission [Body Substance]
   753   C2349995:Emission [Substance]
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "incubated with either Thio T"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "Thio T/BF1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0812297:BF1 [Gene or Genome]
   827   C1705148:BF1 [Gene or Genome]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.176: Calculation of the difference spectrum between the samples demonstrated the presence of an emission maximum at 480 nm, corresponding to the expected wavelength for the Thio T emission (Fig. 4). 

Phrase: "Calculation of the difference spectrum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441506:Calculation [Activity]

Phrase: "between the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "demonstrated"

Phrase: "the presence of an emission maximum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at 480 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "corresponding to the expected wavelength"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449819:Wavelength [Quantitative Concept]
   760   C1517001:Expected [Idea or Concept]

Phrase: "for the Thio T emission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.177: This experiment was repeated by replacing BF1 with BTA-1, which has similar excitation/emission maxima but should directly compete with Thio T for BS1. 

Phrase: "This experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated by replacing BF1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0205341:Repeated [Functional Concept]
   770   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0812297:BF1 [Gene or Genome]
   770   C1299987:replacing [Functional Concept]
   770   C1705148:BF1 [Gene or Genome]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1554078:Replace [Idea or Concept]
   737 E C1705914:Repeat [Conceptual Entity]

Phrase: "with BTA-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "which"

Phrase: "has"

Phrase: "similar excitation/emission maxima"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0806909:Maximum [Quantitative Concept]
   779   C1552615:maximum [Quantitative Concept]
   779   C2826546:MAXIMUM [Quantitative Concept]
   729 E C0205289:Maximal [Qualitative Concept]

Phrase: "but"

Phrase: "should"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "compete with Thio T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for BS1."
Processing 00000000.tx.178: No fluorescent signal was observed at 480 nm with the BTA-1. 

Phrase: "No fluorescent signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "observed at 480 nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C1441672:Observed [Functional Concept]

Phrase: "with the BTA-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]
Processing 00000000.tx.179: These data clearly demonstrate that only BF1 is able to efficiently transfer energy to Thio T consistent with BS1 and BS2 representing spatially independent ligand-binding sites on the A fibrils. 

Phrase: "These data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that only BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0812297:BF1 [Gene or Genome]
   861   C1705148:BF1 [Gene or Genome]

Phrase: "is"

Phrase: "able to efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "energy to Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "consistent with BS1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "BS2"

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "spatially independent ligand-binding sites on the"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0005456:Binding Sites [Receptor]
   778   C1517880:Ligand Binding [Molecular Function]
   748   C0023688:Ligand [Chemical]
   748   C0205145:Sites [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "A fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.180: View larger version (10K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.181: 4. 

Phrase: "4."
Processing 00000000.tx.182: Evidence of FRET between BS1 and BS2. 

Phrase: "Evidence of FRET"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between BS1"

Phrase: "and"

Phrase: "BS2."
Processing 00000000.tx.183: Difference emission spectra (DFLINT) following excitation at 340 nm of A-(140) fibrils incubated with Thio T and either BF1 or BTA-1. 

Phrase: "Difference emission spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "(DFLINT"

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "excitation at 340 nm of A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0549255:Excitation [Activity]

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "incubated with Thio T"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "either BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "or"

Phrase: "BTA-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]
Processing 00000000.tx.184: Only in the presence of BF1 is there a fluorescent signal at the expected emission wavelength of Thio T (480 nm) indicative of energy transfer between the two fluorophores.  

Phrase: "Only in the presence of BF1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205171:Only [Quantitative Concept]
   753   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0812297:BF1 [Gene or Genome]
   753   C1705148:BF1 [Gene or Genome]
   753   C1720467:Only [Intellectual Product]

Phrase: "is"

Phrase: "there"

Phrase: "a fluorescent signal at the expected emission wavelength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "of Thio T (480 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "indicative of energy transfer"

Phrase: "between the two fluorophores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598447:fluorophore [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.185: Radioligand Assays Indicate a Third Class of Binding Site on the A FibrilsIn order to ascertain whether the observed differences in binding affinities between the literature and fluorescent assays reported here were because of the different assay formats, the binding of [3H]Me-BTA-1 to A-(140) fibrils was determined by using a filter binding assay. 

Phrase: "Radioligand Assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034596:Radioligand Assays [Laboratory Procedure]
   861   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "Indicate"

Phrase: "a Third Class of Binding Site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "on the"

Phrase: "A FibrilsIn"

Phrase: "order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "the observed differences in binding affinities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between the literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "fluorescent assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "were because of the different assay formats,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1301627:formats [Intellectual Product]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1705242:Different [Qualitative Concept]

Phrase: "the binding of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1 to A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0053246:benzothiazole [Organic Chemical]
   760   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a filter binding assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.186: The resulting binding isotherm was consistent with the presence of a single high affinity binding site on the polymer with an apparent Kd of 4.2 nM and a maximal binding (Bmax) of 0.13 when measured at 40 nM A monomer concentration (Fig. 5A). 

Phrase: "The resulting binding isotherm"

Phrase: "was"

Phrase: "consistent with the presence of a single high affinity binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "with an apparent Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "of 4.2 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "a maximal binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "(Bmax) of 0.13"

Phrase: "when"

Phrase: "measured at 40 nM"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0312860:NM [Cell Function]
   770   C0439509:/40 [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "A monomer concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.187: The Kd value is slightly higher than the previously reported IC50 value for this compound of 20 nM (7); 

Phrase: "The Kd value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026691:KD [Disease or Syndrome]
   861   C1522609:Value [Quantitative Concept]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "is"

Phrase: "slightly higher than the previously reported IC50 value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "for this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "of 20 nM (7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.188: and the low Bmax value, equating to 1 ligand-binding site per 300 A-(140) monomers, is consistent with that found for other similar compounds such as 6-OH-BTA-1/PIB and BTA-1 (8). 

Phrase: "and"

Phrase: "the low Bmax value,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522609:Value [Quantitative Concept]

Phrase: "equating to 1 ligand-binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   790   C1517880:Ligand Binding [Molecular Function]
   753   C0023688:Ligand [Chemical]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "per 300 A-(140"

Phrase: ")"

Phrase: "monomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "consistent with that"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "found for other similar compounds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0150312:Found [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   726   C0205198:Compound [Qualitative Concept]
   726 E C0243095:Find [Finding]
   726   C1706082:Compound [Chemical]

Phrase: "such as 6-OH-BTA-1/PIB"

Phrase: "and"

Phrase: "BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.189: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.190: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.191: A, binding isotherm for the ligand [3H]Me-BTA-1 with A-(140) fibrils. 

Phrase: "A,"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "isotherm for the ligand"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1 with A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0053246:benzothiazole [Organic Chemical]
   760   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.192: Scatchard analysis is shown in the inset. 

Phrase: "Scatchard analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "shown in the inset."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.193: The Kd and Bmax values derived from this analysis were 4.2 and 0.13 nM respectively. 

Phrase: "The Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "and"

Phrase: "Bmax values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "derived from this analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1441547:Derived [Qualitative Concept]
   770   C1524024:analysis [Functional Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "4.2"

Phrase: "and"

Phrase: "0.13 nM respectively."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]
Processing 00000000.tx.194: B, radioligand competition assays. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "radioligand competition assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034596:Radioligand Assays [Laboratory Procedure]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.195: Dose-response curves showing the fractional binding of [3H]Me-BTA-1 to A-(140) fibrils in the presence of competitor ligands: , Thio T; 

Phrase: "Dose-response curves"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C0683162:dose-response curve [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   793   C0205134:Curve [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the fractional binding of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1 to A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0053246:benzothiazole [Organic Chemical]
   760   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ")"

Phrase: "fibrils in the presence of competitor ligands"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0225328:fibrils [Cell Component]
   714 E C1948066:Fibril [Physical Object]

Phrase: ":"

Phrase: ","

Phrase: "Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.196: x, IMPY-H; 

Phrase: "x,"

Phrase: "IMPY-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "IMPY-H"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.197: +, IMPY-Me; 

Phrase: "+,"

Phrase: "IMPY-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "Me"

Phrase: ";"
Processing 00000000.tx.198: , BF1; 

Phrase: ", BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.199: , TZDM; 

Phrase: ", TZDM"

Phrase: ";"
Processing 00000000.tx.200: , TZPI; 

Phrase: ", TZPI"

Phrase: ";"
Processing 00000000.tx.201: , BTA-1. 

Phrase: ", BTA-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]
Processing 00000000.tx.202: The standard deviations for all points were <10% and are not plotted for clarity.  

Phrase: "The standard deviations for all points"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0871420:Standard deviation [Quantitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C2828392:Standard [Intellectual Product]
   719   C0012727:Deviation [Spatial Concept]
   719   C0205419:Deviation [Qualitative Concept]
   719   C1705236:Deviation [Finding]

Phrase: "were"

Phrase: "<10%"

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "plotted for clarity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0486588:Clarity [Clinical Attribute]
   790   C3272888:Clarity [Laboratory Procedure]
   718 E C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.203: The data from this set of experiments were consistent with the identification of the previously described very low density site on A-(140) fibrils. 

Phrase: "The data from this set of experiments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0150098:Data Set [Intellectual Product]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "consistent with the identification of the previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "very low density site on A-(140"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.204: Given that the ligand-binding characteristics of this site were clearly differentiated from BS1 and BS2, it is suggested that this represents a third class of binding site, termed BS3. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the ligand-binding characteristics of this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "were"

Phrase: "clearly"

Phrase: "differentiated from BS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007589:Differentiated [Cell Function]
   790   C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "BS2,"

Phrase: "it"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a third class of binding site,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "termed BS3."
Processing 00000000.tx.205: In competitive binding assays, all of the ligands tested were able to displace [3H]Me-BTA-1 in a manner consistent with a single class of binding sites on the A fibril (Fig. 5B). 

Phrase: "In competitive binding assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0005458:Binding, Competitive [Molecular Function]

Phrase: "all of the ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023688:Ligands [Chemical]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0085732:Able [Organism Attribute]
   833   C1299581:Able [Finding]

Phrase: "displace"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1 in a manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0053246:benzothiazole [Organic Chemical]
   760   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "consistent with a single class of binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the"

Phrase: "A fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.206: The Ki values derived from these assays were significantly lower than the values derived from both the FLINT2 and Thio T fluorescent competition assays. 

Phrase: "The Ki values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "derived from these assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "significantly lower than the values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "derived from both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "the FLINT2"

Phrase: "and"

Phrase: "Thio T fluorescent competition assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.207: However, again the relative order of binding affinities was conserved between the radioligand and fluorescent assays (Table I). 

Phrase: "However,"

Phrase: "again"

Phrase: "the relative order of binding affinities"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]

Phrase: "was"

Phrase: "conserved between the radioligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "fluorescent assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.208: In addition, the radioligand competition assays have allowed a direct comparison, under a standard set of conditions, of ligand binding to this low density site on the A-(140) fibrils. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the radioligand competition assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034596:Radioligand Assays [Laboratory Procedure]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "have"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "a direct comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "under a standard set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of ligand binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517880:Ligand Binding [Molecular Function]
   861   C0023688:Ligand [Chemical]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to this low density site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.209: The Ki values from the current set of experiments are broadly in agreement with the previously published values for these compounds both in terms of potency and rank order of binding affinity. 

Phrase: "The Ki values from the current set of experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0042295:Values [Qualitative Concept]
   708 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "broadly in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the previously published values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "for these compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "both in terms of potency"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]
   726   C1515273:Term [Temporal Concept]
   726   C1705313:Term [Idea or Concept]
   726   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "rank order of binding affinity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0699794:Rank [Intellectual Product]
   760   C1705175:Order [Intellectual Product]
   760   C1705176:Order [Qualitative Concept]
   760   C1705177:Order [Classification]
   760   C1705178:Order [Activity]
   760   C1882348:Order [Qualitative Concept]
Processing 00000000.tx.210: The inability to detect ligand binding at BS3 by using fluorescent techniques may be due to a number of related factors. 

Phrase: "The inability to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "ligand binding at BS3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1517880:Ligand Binding [Molecular Function]
   770   C0023688:Ligand [Chemical]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescent techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "may"

Phrase: "be due to a number of related factors."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   750   C0960756:factor A [Organic Chemical]
   744   C0237753:*Number [Quantitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0449788:Number [Quantitative Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.211: The relative contribution of this site to a binding signal (whether FLINT or anisotropy) would be small relative to the more densely packed BS1 and BS2. 

Phrase: "The relative contribution of this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "to a binding signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "("

Phrase: "whether"

Phrase: "FLINT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "anisotropy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085406:Anisotropy [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "would"

Phrase: "be"

Phrase: "small relative to the more densely packed BS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "BS2."
Processing 00000000.tx.212: By assuming that a ligand produced an identical FLINT increase when bound to any of the sites, the observed signal from BS3 would be a tenth or a hundredth smaller than that observed at BS1 and BS2, respectively. 

Phrase: "By"

Phrase: "assuming"

Phrase: "that"

Phrase: "a ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "produced"

Phrase: "an identical FLINT increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "when"

Phrase: "bound to any of the sites,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   767   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "the observed signal from BS3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "would"

Phrase: "be"

Phrase: "a tenth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205444:Tenth [Quantitative Concept]

Phrase: "or"

Phrase: "a hundredth"

Phrase: "smaller than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "observed at BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "BS2,"

Phrase: "respectively."
Processing 00000000.tx.213: In addition, it is possible that ligand binding to BS3 may significantly quench or produce no change in ligand fluorescence making it difficult to detect by either FLINT or anisotropy measurements. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that ligand binding to BS3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1517880:Ligand Binding [Molecular Function]
   760   C0023688:Ligand [Chemical]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "may"

Phrase: "significantly"

Phrase: "quench"

Phrase: "or"

Phrase: "produce"

Phrase: "no change in ligand fluorescence making"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "it difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "detect by either FLINT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0442726:detect [Finding]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "or"

Phrase: "anisotropy measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.214: Evidence That BS1, BS2, and BS3 Are Uniformly Distributed on the A FibrilsAlthough the FRET data were able to demonstrate that BS1 and BS2 were in close proximity on the same A fibril, the radioligand data do not directly imply that BS3 is also distributed on the same population of fibrils. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "That BS1,"

Phrase: "BS2,"

Phrase: "and"

Phrase: "BS3"

Phrase: "Are"

Phrase: "Uniformly"

Phrase: "Distributed on the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704711:Distributed [Functional Concept]

Phrase: "A FibrilsAlthough"

Phrase: "the FRET data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "that BS1"

Phrase: "and"

Phrase: "BS2"

Phrase: "were in close proximity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]

Phrase: "on the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "A fibril,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]

Phrase: "the radioligand data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "imply"

Phrase: "that BS3"

Phrase: "is"

Phrase: "also"

Phrase: "distributed on the same population of fibrils."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0032659:Population [Quantitative Concept]
   748   C0225328:fibrils [Cell Component]
   748   C0445247:Same [Qualitative Concept]
   748   C1257890:Population [Population Group]
   748   C1704711:Distributed [Functional Concept]
   714 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.215: To address this issue, we separated the A fibrils by density gradient ultracentrifugation using a method adapted from Ward et al. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "the A fibrils by density gradient ultracentrifugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0225328:fibrils [Cell Component]
   714 E C1948066:Fibril [Physical Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "adapted from Ward et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1305702:Ward [Health Care Related Organization,Manufactured Object]
   760   C1547134:Ward [Idea or Concept]
   760   C2355574:Ward [Population Group]
   760   C2937289:adapted [Organic Chemical]
Processing 00000000.tx.216: (27), and we assayed the resulting fractions for A immunoreactivity and thioflavin T and [3H]Me-BTA-1 binding (Fig. 6). 

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "the resulting fractions for A immunoreactivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "thioflavin T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1 binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.217: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 6. 

Phrase: "6."
Processing 00000000.tx.219: Analysis of fractions from the density gradient centrifugation of A fibrils. 

Phrase: "Analysis of fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "from the density gradient centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0178587:density [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "of A fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.220: , TT fluorescence (arbitrary units); 

Phrase: ", TT fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.221: , 6E10 immunoreactivity (arbitrary units); 

Phrase: ", 6E10 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "(arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.222: , [3H]Me-BTA-1 dpm (x10). 

Phrase: ","

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1 dpm (x10"

Phrase: ")."
Processing 00000000.tx.223: Inset shows a blot of the fractions using the 6E10 antibody. 

Phrase: "Inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a blot of the fractions"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 6E10 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.224: Note that fraction 1 contains the most dense material and fraction 12 the least dense material.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that fraction 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the most dense material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3546235:dense material [Cell Component]
   827   C0520510:Material [Substance]

Phrase: "and"

Phrase: "fraction 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "the least dense material."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3546235:dense material [Cell Component]
   827   C0520510:Material [Substance]
Processing 00000000.tx.225: Based on the immunoreactivity of the anti-A antibody 6E10, the centrifugation step split the fibrillar preparation into two peaks centered on fractions 3 and 5. 

Phrase: "Based on the immunoreactivity of the anti-A antibody 6E10,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0597879:immunoreactivity [Molecular Function]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the centrifugation step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "split"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "the fibrillar preparation into two peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0455052:Preparation [Health Care Activity]
   753   C1521827:Preparation [Functional Concept]

Phrase: "centered on fractions 3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205099:centered [Spatial Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.226: The vast majority (80%) of the signal from the blot is present in fraction 3, and this is consistent with the expected high molecular mass of the A fibrils and similar to that found previously using this method (27). 

Phrase: "The vast majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680220:majority [Social Behavior]

Phrase: "(80%"

Phrase: ")"

Phrase: "of the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "from the blot"

Phrase: "is"

Phrase: "present in fraction 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "this"

Phrase: "is"

Phrase: "consistent with the expected high molecular mass of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
   726   C2983632:Mass Consistency [Qualitative Concept]

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "previously"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.227: Fraction 5 is a small shoulder on the main peak of A immunoreactivity indicative of a second population of high molecular mass species in the fibrillar preparation, although of lesser mass than fraction 3. 

Phrase: "Fraction 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "a small shoulder on the main peak of A immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0037004:Shoulder [Body Location or Region]
   739   C1283792:Shoulder [Body Location or Region]

Phrase: "indicative of a second population of high molecular mass species"

Phrase: "in the fibrillar preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "although of lesser mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0547044:Lesser [Qualitative Concept]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "than fraction 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.228: The ligand binding properties of both Thio T (BS1 probe) and [3H]Me-BTA-1 (BS3 probe) to these fractions display an identical pattern both to each other and also to the signal obtained from the A immunoblot. 

Phrase: "The ligand binding properties of both Thio T (BS1 probe"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]

Phrase: ")"

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(BS3 probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "to these fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "an identical pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "both to each other"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "also to the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "obtained from the"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "A immunoblot."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.229: These findings support the idea that the ligand-binding sites are uniformly distributed across the A fibril preparation and are not restricted to morphologically distinct subpopulations of polymers.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "the ligand-binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0005456:Binding Sites [Receptor]
   901   C1517880:Ligand Binding [Molecular Function]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0023688:Ligand [Chemical]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "uniformly"

Phrase: "distributed across the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704711:Distributed [Functional Concept]

Phrase: "A fibril preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: "to morphologically distinct subpopulations of polymers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1257890:Subpopulation [Population Group]
Processing 00000000.tx.230: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The development of potentially useful PET ligands for the detection of SPs is being widely pursued because of the clinical importance such imaging would have (6). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The development of potentially useful PET ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243107:development [Physiologic Function]
   742   C0678723:Development [Organism Function]
   742   C1527148:Development [Functional Concept]

Phrase: "for the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of SPs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "is"

Phrase: "being"

Phrase: "widely"

Phrase: "pursued because of the clinical importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205210:Clinical [Qualitative Concept]

Phrase: "such"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "would"

Phrase: "have"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.231: However, until now, the binding properties of these prospective PET ligands to A fibrils have not been rigorously examined, raising doubts over the true significance of the clinical investigations performed to date. 

Phrase: "However,"

Phrase: "until"

Phrase: "now,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "the binding properties of these prospective PET ligands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]

Phrase: "to A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "rigorously"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "raising"

Phrase: "doubts over the true significance of the clinical investigations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0870444:doubts [Mental Process]

Phrase: "performed to date."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C0884358:Performed [Functional Concept]
   790   C2348077:Date [Food]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.232: We have developed and performed a range of assays that, for the first time, have allowed a full analysis of the binding of a series of Thio T derivatives to A-(140) fibrils in vitro. 

Phrase: "We"

Phrase: "have"

Phrase: "developed"

Phrase: "and"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a range of assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "that,"

Phrase: "for the first time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "have"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "a full analysis of the binding of a series of Thio T derivatives"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0002778:Analysis [Laboratory Procedure]
   735   C0936012:Analysis [Research Activity]
   735   C1524024:analysis [Functional Concept]

Phrase: "to A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.233: Our data are consistent with the presence of a previously described binding site (BS3) to which all of the compounds bind with high affinity, but it also demonstrates the presence of two additional high affinity and much more abundant binding sites (BS1 and BS2). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the presence of a previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(BS3"

Phrase: ")"

Phrase: "to which"

Phrase: "all of the compounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "bind with high affinity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205250:High [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "but"

Phrase: "it also"

Phrase: "demonstrates"

Phrase: "the presence of two additional high affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "much more abundant binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0005456:Binding Sites [Receptor]
   806 E C0682969:Binding Site [Amino Acid Sequence]
   804   C0205145:Sites [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "(BS1"

Phrase: "and"

Phrase: "BS2"

Phrase: ")."
Processing 00000000.tx.234: The finding of these additional binding sites on the A-(140) fibrils may help resolve issues surrounding the nature of the signal detected in vivo by PET with these ligands. 

Phrase: "The finding of these additional binding sites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1285538:Finding site [Functional Concept]
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0033213:Issue [Finding]
   966   C1706387:Issue [Intellectual Product]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the nature of the signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in vivo by PET"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "with these ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]
Processing 00000000.tx.235: A number of lines of evidence support the presence of multiple ligand-binding sites on the A-(140) polymers. 

Phrase: "A number of lines of evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the presence of multiple ligand-binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]
Processing 00000000.tx.236: First, both the Kd and Ki values from two independent fluorescence-based assay formats are significantly higher than the values reported from previous and the currently described radioligand binding assays. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "both"

Phrase: "the Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "and"

Phrase: "Ki values from two independent fluorescence-based assay formats"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0042295:Values [Qualitative Concept]
   708 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "significantly higher than the values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "reported from previous"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0205156:Previous [Temporal Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1552607:previous [Temporal Concept]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "the currently described radioligand binding assays."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0034596:Radioligand Assays [Laboratory Procedure]
   804   C0243122:binding [Functional Concept]
   804   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.237: This provides direct evidence of additional ligand-binding sites on the A-(140) fibrils. 

Phrase: "This"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "direct evidence of additional ligand-binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.238: In addition, the FLINT assays also demonstrated that the binding site densities of BS1 and BS2 are significantly higher than that of BS3. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the FLINT assays also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the binding site densities of BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:densities [Quantitative Concept]

Phrase: "and"

Phrase: "BS2"

Phrase: "are"

Phrase: "significantly higher than that of BS3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.239: Finally, the selectivity of compounds containing a halogen substitution on their aromatic ring systems (TZDM/TZPI/BF1) provides a structural discriminator for BS1 and BS2. 

Phrase: "Finally,"

Phrase: "the selectivity of compounds"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a halogen substitution on their aromatic ring systems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1555721:Substitution [Idea or Concept]
   744   C1706204:Substitution [Activity]

Phrase: "(TZDM/TZPI/BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0812297:BF1 [Gene or Genome]
   827   C1705148:BF1 [Gene or Genome]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a structural discriminator for BS1"

Phrase: "and"

Phrase: "BS2."
Processing 00000000.tx.240: The ability of BS3 to accommodate both halogen- and nonhalogen-containing structures suggests a hybrid-binding site that occurs periodically only when BS1 and BS2 are in complete register on the fibril. 

Phrase: "The ability of BS3 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "accommodate"

Phrase: "both halogen-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018544:Halogen [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "nonhalogen-containing structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a hybrid-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "periodically only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0332182:Periodically [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "BS1"

Phrase: "and"

Phrase: "BS2"

Phrase: "are in complete register"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205197:Complete [Qualitative Concept]
   770   C0725685:COMPLEAT [Food]
   770   C1551058:Are [Quantitative Concept]

Phrase: "on the fibril."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]
Processing 00000000.tx.241: However, the significantly different binding constants for ligands between BS1/2 and BS3 would argue that the latter site is a spatially distinct periodic feature of the polymer. 

Phrase: "However,"

Phrase: "the significantly different binding constants for ligands"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C1517880:Ligand Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   714   C1547014:*Constant [Quantitative Concept]
   714   C1948059:Constant [Qualitative Concept]

Phrase: "between BS1/2"

Phrase: "and"

Phrase: "BS3"

Phrase: "would"

Phrase: "argue"

Phrase: "that"

Phrase: "the latter site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "a spatially distinct periodic feature of the polymer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.242: A schematic demonstrating the potential arrangement of binding sites on the A-(140) fibril is shown in Fig. 

Phrase: "A schematic"

Phrase: "demonstrating"

Phrase: "the potential arrangement of binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449830:Arrangement [Spatial Concept]

Phrase: "on the A-(140"

Phrase: ")"

Phrase: "fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.243: 7. 

Phrase: "7."
Processing 00000000.tx.244: This model proposes that all three types of binding sites are present together on the majority of A fibrils in the polymerized mixture and takes into account the FRET data demonstrating the close spatial proximity of BS1 and BS2 and the congruent distribution of fluorescence and radioligand-binding sites following fractionation of polymers by density gradient centrifugation. 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "proposes"

Phrase: "that"

Phrase: "all three types of binding sites"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0332307:Types [Qualitative Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "together on the majority of A fibrils"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0225328:fibrils [Cell Component]
   748   C0680220:majority [Social Behavior]
   748   C1883357:Together [Qualitative Concept]
   714 E C1948066:Fibril [Physical Object]

Phrase: "in the polymerized mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "takes into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the FRET data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "demonstrating"

Phrase: "the close spatial proximity of BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514583:Proximity [Spatial Concept]

Phrase: "and"

Phrase: "BS2"

Phrase: "and"

Phrase: "the congruent distribution of fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "radioligand-binding sites"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0005456:Binding Sites [Receptor]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "fractionation of polymers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016640:fractionation [Laboratory Procedure]
   790   C0524811:fractionation [Therapeutic or Preventive Procedure]
   790   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "by density gradient centrifugation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0178587:density [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.245: View larger version (11K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.246: 7. 

Phrase: "7."
Processing 00000000.tx.247: A model of binding sites on A fibrils for the Thio T class of ligands. 

Phrase: "A model of binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "on A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "for the Thio T class"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "of ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]
Processing 00000000.tx.248: BS3 is the previously described independent low density site. 

Phrase: "BS3"

Phrase: "is"

Phrase: "the previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "independent low density site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.249: BS1 and BS2 are the newly identified higher density sites that are independent from BS3. 

Phrase: "BS1"

Phrase: "and"

Phrase: "BS2"

Phrase: "are"

Phrase: "the newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "higher density sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "independent from BS3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085862:Independent [Idea or Concept]
   790   C1299583:Independent [Finding]
Processing 00000000.tx.250: The arrangement of BS1 and BS2 schematically reflects how differences in their relative polymer density can lead to the sites periodically occurring in close proximity and/or partially overlapping. 

Phrase: "The arrangement of BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449830:Arrangement [Spatial Concept]

Phrase: "and"

Phrase: "BS2 schematically"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "how differences in their relative polymer density"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "can"

Phrase: "lead to the sites periodically"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205145:Sites [Spatial Concept]
   760   C0332182:Periodically [Temporal Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "occurring in close proximity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]

Phrase: "and/or"

Phrase: "partially"

Phrase: "overlapping."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]
Processing 00000000.tx.251: The short and long arrows indicate how both displacement and FRET can occur between BS1 and BS2, respectively.  

Phrase: "The short"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1282927:short [Qualitative Concept]
  1000   C1806781:Short [Quantitative Concept]
  1000   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "long arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "how"

Phrase: "both displacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012725:Displacement [Mental Process]
  1000   C0012727:Displacement [Spatial Concept]
  1000   C0456080:Displacement [Qualitative Concept]
  1000   C2347509:Displacement [Phenomenon or Process]

Phrase: "and"

Phrase: "FRET"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0014274:Energy Transfer [Molecular Function]
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0040671:Transfer [Mental Process]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]
   827   C1705822:Transfer [Activity]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "can"

Phrase: "occur between BS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "BS2,"

Phrase: "respectively."
Processing 00000000.tx.252: A high resolution structure of amyloid fibrils formed from A peptides is not available, making it difficult to associate the ligand-binding sites with structural features on the polymer. 

Phrase: "A high resolution structure of amyloid fibrils"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1719039:High resolution [Laboratory Procedure]
   748   C0205250:High [Qualitative Concept]
   748   C0678594:Structure [Spatial Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1514893:Resolution [Idea or Concept]
   748   C1706463:Resolution [Quantitative Concept]
   748   C2699488:Resolution [Conceptual Entity]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "formed from A peptides"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0205431:Formed [Functional Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "not available,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "the ligand-binding sites with structural features"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0005456:Binding Sites [Receptor]
   778   C1517880:Ligand Binding [Molecular Function]
   748   C0023688:Ligand [Chemical]
   748   C0205145:Sites [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "on the polymer."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]
Processing 00000000.tx.253: The increase in the intrinsic fluorescence of the ligands is indicative of compound binding into a hydrophobic pocket on the polymer and suggests that BS1 and BS2 are associated with the two hydrophobic clusters (residues 1721 and 3040) on the A peptide (reviewed in Ref. 28). 

Phrase: "The increase in the intrinsic fluorescence of the ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "indicative of compound binding"

Phrase: "into a hydrophobic pocket"

Phrase: "on the polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BS1"

Phrase: "and"

Phrase: "BS2"

Phrase: "are"

Phrase: "associated with the two hydrophobic clusters"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205448:Two [Quantitative Concept]
   753   C0598629:Hydrophobic [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719   C1555715:Cluster [Idea or Concept]
   719   C1704332:Cluster [Quantitative Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(residues 1721"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "3040"

Phrase: ")"

Phrase: "on the"

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "reviewed in Ref. 28"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.254: The presence of multiple classes of binding sites on the A fibrils is also supported by two studies using the ligand FDDNP. 

Phrase: "The presence of multiple classes of binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on the"

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "is"

Phrase: "also"

Phrase: "supported by two studies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ligand FDDNP."
Processing 00000000.tx.255: The first study using a radioligand filter binding assay indicated that [18F]FDDNP was not displaceable by Thio T from A-(140) fibrils (29). 

Phrase: "The first study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a radioligand filter binding assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0034596:Radioligand Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "[18F"

Phrase: "]FDDNP"

Phrase: "was"

Phrase: "not displaceable by Thio T"

Phrase: "from A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.256: However, a recent study (30) demonstrated that, in a fluorescent competition assay using Thio T and A-(140) fibrils (in an essentially identical format to that described here), FDDNP was able to displace Thio T. 

Phrase: "However,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(30"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that,"

Phrase: "in a fluorescent competition assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "A-(140"

Phrase: ")"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "("

Phrase: "in an essentially identical format"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301627:Format [Intellectual Product]

Phrase: "to that"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: ")"

Phrase: ","

Phrase: "FDDNP"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0085732:Able [Organism Attribute]
   833   C1299581:Able [Finding]

Phrase: "displace"

Phrase: "Thio T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.257: These findings are consistent with the presence of both independent and common/overlapping binding sites on the fibrils. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the presence of both independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "common/overlapping binding sites on the fibrils."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0005456:Binding Sites [Receptor]
   774   C0456206:Overlapping sites [Spatial Concept]
   748   C0205145:Sites [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.258: The increase in the intrinsic fluorescence of Thio T has been exploited through its use as a histological dye in the postmortem diagnosis of AD (31, 32). 

Phrase: "The increase in the intrinsic fluorescence of Thio T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "exploited through its use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "as a histological dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in the postmortem diagnosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332145:Postmortem Diagnosis [Finding]
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of AD (31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.259: Our findings would suggest that the signal obtained in the post-mortem tissue is primarily associated with its interaction with BS1 and would also suggest that the fluorescent signal associated with the use of these Thio T derivatives in histological studies, when the compounds are used at relatively high concentrations (>100 nM), is not from BS3 but primarily from the large increase in FLINT associated with the higher density BS1 and BS2. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "obtained in the post-mortem tissue"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0444184:Postmortem tissue [Tissue]
   790   C0004398:postmortem [Diagnostic Procedure]
   790   C0580205:Postmortem [Temporal Concept]
   790   C0848632:post mortem [Finding]
   753   C0040300:Tissue [Tissue]
   753   C0687676:Post [Temporal Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1704687:Post [Manufactured Object]
   719 E C1706701:Obtain [Activity]

Phrase: "is"

Phrase: "primarily"

Phrase: "associated with its interaction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1704675:Interaction [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "with BS1"

Phrase: "and"

Phrase: "would"

Phrase: "also"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the fluorescent signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "associated with the use of these Thio T derivatives"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1524063:Use of [Functional Concept]
   742   C0042153:use [Functional Concept]
   742   C0243072:derivatives [Chemical Viewed Structurally]
   742   C0457083:Use [Functional Concept]
   742   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C1947944:Use [Intellectual Product]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1527240:Derivative [Functional Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in histological studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   933   C0681853:histologic study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "when"

Phrase: "the compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "are"

Phrase: "used at relatively high concentrations"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0086045:Concentrations [Mental Process]
   760   C0205250:High [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "("

Phrase: ">100 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "is"

Phrase: "not from BS3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "but"

Phrase: "primarily from the large increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C0549177:Large [Quantitative Concept]

Phrase: "in FLINT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "associated with the higher density BS1"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0178587:density [Quantitative Concept]
   719   C0205250:High [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719   C1299351:High [Qualitative Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "BS2."
Processing 00000000.tx.260: An approximate rule for the success of a radioligand in in vivo imaging experiments makes use of the term binding potential (BP) which is the sum of Bmax/Kd; 

Phrase: "An approximate rule for the success of a radioligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0805874:Rule [Idea or Concept]
   742   C0870077:Rule [Intellectual Product]
   742   C1446409:rule [Qualitative Concept]

Phrase: "in in vivo imaging experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   756   C1708481:In Vivo Imaging [Laboratory Procedure]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "use of the term binding potential (BP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "the sum of Bmax/Kd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515051:Sum [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.261: values >10 generally produce a sufficient signal for PET studies (8). 

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: ">10 generally"

Phrase: "produce"

Phrase: "a sufficient signal for PET studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.262: The in vivo value of Bmax necessary for the calculation of the BP has not been determined, however, Nslund et al. 

Phrase: "The in vivo value of Bmax"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "necessary for the calculation of the BP"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined"

Phrase: ","

Phrase: "however,"

Phrase: "Nslund et al."
Processing 00000000.tx.263: (17) have calculated the regional distribution of total A-(140) and A-(142) levels (soluble and plaque) in formic acid extracts of post-mortem brains from both control and AD cohorts. 

Phrase: "(17"

Phrase: ")"

Phrase: "have"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "the regional distribution of total A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A-(142"

Phrase: ")"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "(soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "plaque"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011389:Plaque [Disease or Syndrome]
  1000   C0332461:Plaque [Finding]
  1000   C0333463:plaque [Acquired Abnormality]

Phrase: ")"

Phrase: "in formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "extracts of post-mortem brains"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0004398:postmortem [Diagnostic Procedure]
   806   C0580205:Postmortem [Temporal Concept]
   806   C0848632:post mortem [Finding]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0687676:Post [Temporal Concept]
   760   C1704687:Post [Manufactured Object]
   760   C2828366:Extract [Substance]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "AD cohorts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:cohorts [Population Group]
Processing 00000000.tx.264: Their findings suggest that levels of total A load approached 13 M in the cortical regions of AD brains. 

Phrase: "Their findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that levels of total"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "A load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "approached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449445:Approach [Spatial Concept]

Phrase: "13 M in the cortical regions of AD brains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.265: By using the mid-point of the data set together with the Kd of 4.2 nM for [3H]Me-BTA-1, a BP of 500 is obtained. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mid-point of the data set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1511726:Data Point [Idea or Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]

Phrase: "together with the Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "of 4.2 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "for"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]Me-BTA-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "a BP of 500"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986841:Binding Potential [Phenomenon or Process]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "is"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.266: However, when the in vitro binding stoichiometry of the radioligand binding to BS3 is taken into account, the BP is reduced to 2, which is unlikely to generate a significant PET signal in vivo. 

Phrase: "However,"

Phrase: "when"

Phrase: "the in vitro binding stoichiometry of the radioligand binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "to BS3"

Phrase: "is"

Phrase: "taken into account,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C1883727:Taken [Conceptual Entity]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756 E C1515187:Take [Health Care Activity]

Phrase: "the BP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986841:Binding Potential [Phenomenon or Process]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C3245505:Potential [Qualitative Concept]

Phrase: "is"

Phrase: "reduced to 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "generate"

Phrase: "a significant PET signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1710082:Signal [Phenomenon or Process]
   717   C0032743:Positron-Emission Tomography [Diagnostic Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.267: Although higher Bmax values have been reported for BTA-1 and PIB binding to AD brain homogenates, the levels of A peptides in this study were not explicitly measured (8). 

Phrase: "Although"

Phrase: "higher Bmax values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported for BTA-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0053246:benzothiazole [Organic Chemical]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   790   C3536937:Benzothiazole [Pharmacologic Substance]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "PIB binding to AD brain homogenates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "the levels of A peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "not explicitly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.268: One key question that arises from the present set of studies is as follows: what might be relative potential contributions of BS1 and BS2 compared with BS3 in the signal obtained from a PET study? 

Phrase: "One key"

Phrase: "question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "that"

Phrase: "arises from the present set of studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0036849:Set [Mental Process]
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "what"

Phrase: "might"

Phrase: "be"

Phrase: "relative potential contributions of BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "BS2"

Phrase: "compared with BS3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "obtained from a PET study?"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   748   C0032744:Positron [Quantitative Concept]
   748   C0040395:tomography [Diagnostic Procedure]
   748   C0040405:tomography [Diagnostic Procedure]
   748   C0233929:Emission [Body Substance]
   748   C0557651:Study [Manufactured Object]
   748   C1301820:Obtained [Functional Concept]
   748   C2349995:Emission [Substance]
   748   C2603343:Study [Research Activity]
   714 E C1706701:Obtain [Activity]
Processing 00000000.tx.269: Using BTA-1 (Ki 200 nM), BF1 (Kd 110 nM), and Me-BTA-1 (Kd 4.2 nM) as model compounds for BS1, BS2, and BS3 and taking into account the stoichiometry of these sites (1:35, 1:4, and 1:300), the levels of A peptides required to produce a BP of 10 are 70, 4, and 12 M respectively. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(Ki 200 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "BF1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "(Kd 110 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "Me-BTA-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053246:benzothiazole [Organic Chemical]
   861   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "(Kd 4.2 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "as"

Phrase: "model compounds for BS1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "BS2,"

Phrase: "and"

Phrase: "BS3"

Phrase: "and"

Phrase: "taking into"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the stoichiometry of these sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "35,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4,"

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300"

Phrase: ")"

Phrase: ","

Phrase: "the levels of A peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "a BP of 10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986841:Binding Potential [Phenomenon or Process]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "are"

Phrase: "70,"

Phrase: "4,"

Phrase: "and"

Phrase: "12 M respectively."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.270: The values for all of the compounds are clearly at the top end of the reported concentrations for A peptides but suggest that BS2 may make a more significant contribution than BS1 and potentially BS3 to the observed PET signals. 

Phrase: "The values for all of the compounds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "clearly at the top end of the reported concentrations"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0086045:Concentrations [Mental Process]
   742   C0444930:End [Spatial Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1704458:Top [Spatial Concept]
   742   C2746065:End [Temporal Concept]
   742   C3496591:Reported [Clinical Attribute]
   708 E C1446561:Concentration [Quantitative Concept]
   708 E C3273238:Report [Intellectual Product]

Phrase: "for A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BS2"

Phrase: "may"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "a more significant contribution than BS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "potentially BS3 to the observed PET signals."
Processing 00000000.tx.271: These data also suggest that the design of higher affinity compounds targeting BS2 may result in improved PET ligands for imaging plaque deposits. 

Phrase: "These data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the design of higher affinity compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1707689:Design [Activity]
   753   C2983265:DESIGN [Intellectual Product]

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "BS2"

Phrase: "may"

Phrase: "result in improved PET ligands"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   748   C0023688:Ligands [Chemical]
   748   C0032744:Positron [Quantitative Concept]
   748   C0040395:tomography [Diagnostic Procedure]
   748   C0040405:tomography [Diagnostic Procedure]
   748   C0184511:Improved [Qualitative Concept]
   748   C0233929:Emission [Body Substance]
   748   C0332272:Improved [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1561611:Improved [Intellectual Product]
   748   C2349995:Emission [Substance]
   748   C2825142:Result [Finding]

Phrase: "for imaging plaque deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.272: In addition, the radioligand assays currently widely in use for compound screening and selection may be targeting the "wrong" site on the fibrils, the low density BS3, and that fluorescence-based screens, such as those using Thio T, may identify compounds with more desirable properties for in vivo imaging studies. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the radioligand assays currently widely in use for compound screening"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0042153:use [Functional Concept]
   739   C0457083:Use [Functional Concept]
   739   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "may"

Phrase: "be"

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the ""wrong"" site on the fibrils,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "the low density BS3,"

Phrase: "and"

Phrase: "that fluorescence-based screens,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0220908:screen [Health Care Activity]
   793   C1305399:screen [Functional Concept]
   793   C1705053:Screen [Medical Device]

Phrase: "such as those"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Thio T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "may"

Phrase: "identify"

Phrase: "compounds with more desirable properties"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205198:Compound [Qualitative Concept]
   726   C1706082:Compound [Chemical]

Phrase: "for in vivo imaging studies."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   923   C1708481:In Vivo Imaging [Laboratory Procedure]
   906   C0681829:in vivo study [Research Activity]
   827   C1881134:Image Study [Diagnostic Procedure]
   812   C0011923:Imaging [Diagnostic Procedure]
   812   C0079595:Imaging [Diagnostic Procedure]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C1704254:Image [Intellectual Product]
   779 E C1704922:Image [Entity]
   779 E C2603343:Study [Research Activity]
   779 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.273: In conclusion, our data support a complex model for the binding of PET radioligands being designed for tracking SPs in AD, with the presence of multiple ligand-binding sites on A fibrils. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a complex model for the binding of PET radioligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C3161035:Model [Intellectual Product]

Phrase: "being"

Phrase: "designed for tracking SPs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   760   C0392079:Senile [Finding]
   760   C0546881:Tracking [Spatial Concept]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0040594:Track [Manufactured Object]
   726 E C0332461:Plaque [Finding]
   726   C1707689:Design [Activity]
   726   C2983265:DESIGN [Intellectual Product]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]

Phrase: "in AD,"

Phrase: "with the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of multiple ligand-binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0005456:Binding Sites [Receptor]
   861   C1517880:Ligand Binding [Molecular Function]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0023688:Ligand [Chemical]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "on A fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.274: The development of therapy for AD is presently hampered by the fact that there is no sensitive test of the progression and regression of the underlying pathology before cognition is affected (6). 

Phrase: "The development of therapy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0556496:Developmental therapy [Therapeutic or Preventive Procedure]
   783   C1522647:Developmental Therapy [Research Activity]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "for AD"

Phrase: "is"

Phrase: "presently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750528:presently [Idea or Concept]

Phrase: "hampered by the fact"

Phrase: "that there"

Phrase: "is"

Phrase: "no sensitive test of the progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]

Phrase: "and"

Phrase: "regression of the underlying pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]

Phrase: "before cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.275: Understanding the properties of A fibrils will assist in the more rational design of more effective specific PET radioligands to track the progression of this disease and accelerate the development of treatments.  

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the properties of A fibrils"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "will"

Phrase: "assist in the more rational design"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018896:assist [Social Behavior]
   753   C0557034:assist [Health Care Activity]
   753   C1707689:Design [Activity]
   753   C2983265:DESIGN [Intellectual Product]

Phrase: "of more effective specific PET radioligands to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]

Phrase: "track"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "the progression of this disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0242656:Disease Progression [Pathologic Function]
           progression
   797   C1947900:Disease progression NOS [Finding]
   760   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the development of treatments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
Processing 00000000.tx.276: FOOTNOTES  * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.277: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.278: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.279: To whom correspondence should be addressed: GlaxoSmithKline, ACCI, Box 128, Addenbrookes Hospital, Hills Road, Cambridge CB2 2GG, UK. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "GlaxoSmithKline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1546895:GlaxoSmithKline [Health Care Related Organization]

Phrase: "ACCI,"

Phrase: "Box 128,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Addenbrookes Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Hills Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Cambridge CB2 2GG,"

Phrase: "UK."
Processing 00000000.tx.280: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.281: 44-1223-296077; 

Phrase: "44-1223-296077"

Phrase: ";"
Processing 00000000.tx.282: Fax: 44-1223-296063; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "44-1223-296063"

Phrase: ";"
Processing 00000000.tx.283: E-mail: andrew.2.lockhart{at}gsk.com . 1 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "andrew.2.lockhart{at}gsk.com . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1325174:GSK [Molecular Function]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.284: A, amyloid -peptide; 

Phrase: "A,"

Phrase: "amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.285: SP, senile plaque; 

Phrase: "SP,"

Phrase: "senile plaque"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   861   C0011389:Plaque [Disease or Syndrome]
   861   C0332461:Plaque [Finding]
   861   C0392079:Senile [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: ";"
Processing 00000000.tx.286: NFT, neurofibrillary tangle; 

Phrase: "NFT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "neurofibrillary tangle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.287: PET, positron emission tomography; 

Phrase: "PET,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: "positron emission tomography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: ";"
Processing 00000000.tx.288: FLINT, fluorescence intensity; 

Phrase: "FLINT,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.289: FRET, fluorescence energy transfer; 

Phrase: "FRET,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0014274:Energy Transfer [Molecular Function]
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0040671:Transfer [Mental Process]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]
   827   C1705822:Transfer [Activity]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fluorescence energy transfer"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0014274:Energy Transfer [Molecular Function]
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0040671:Transfer [Mental Process]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]
   827   C1705822:Transfer [Activity]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.290: BP, binding potential; 

Phrase: "BP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986841:Binding Potential [Phenomenon or Process]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C3245505:Potential [Qualitative Concept]

Phrase: "binding potential"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986841:Binding Potential [Phenomenon or Process]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C3245505:Potential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.291: Thio T, thioflavin T; 

Phrase: "Thio T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "thioflavin T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.292: BTA-1, 2-[4'-(methylamino)phenyl]benzothiazole; 

Phrase: "BTA-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(methylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]benzothiazole"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053246:benzothiazole [Organic Chemical]
  1000   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.293: 6-Me-BTA-1, 2-[4'-(methylamino)phenyl]-6-methylbenzothiazole; 

Phrase: "6-Me-BTA-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0053246:benzothiazole [Organic Chemical]
   827   C3536937:Benzothiazole [Pharmacologic Substance]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(methylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-methylbenzothiazole"

Phrase: ";"
Processing 00000000.tx.294: IMPY-H, 2-(4'-dimethylamino-)phenyl-imidazo[1,2-a]-pyridine; 

Phrase: "IMPY-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "IMPY-H,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(4'-dimethylamino-"

Phrase: ")"

Phrase: "phenyl-imidazo"

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-a]-pyridine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034251:pyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0034255:Pyridine [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.295: IMPY-Me, 6-methyl-2-(4'-dimethylamino)phenyl-imidazo[1,2-a]-pyridine; 

Phrase: "IMPY-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045368:IMPY [Organic Chemical,Pharmacologic Substance]

Phrase: "Me,"

Phrase: "6-methyl-2-"

Phrase: "(4'-dimethylamino"

Phrase: ")"

Phrase: "phenyl-imidazo"

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-a]-pyridine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034251:pyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0034255:Pyridine [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.296: TZDM, 2-[4'-(dimethylamino)phenyl]-6-iodobenzothiazole; 

Phrase: "TZDM,"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(dimethylamino"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole"

Phrase: ";"
Processing 00000000.tx.297: TZPI, 2-[4'-(4''-methylpiperazin-1-yl)phenyl]-6-iodobenzothiazole; 

Phrase: "TZPI,"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4'-"

Phrase: "(4''-methylpiperazin-1-yl"

Phrase: ")"

Phrase: "phenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "]-6-iodobenzothiazole"

Phrase: ";"
Processing 00000000.tx.298: BF1, 5-bromo-2-(4-dimethylaminophenyl)benzofuran; 

Phrase: "BF1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0290266:BF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812297:BF1 [Gene or Genome]
  1000   C1705148:BF1 [Gene or Genome]

Phrase: "5-bromo-2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(4-dimethylaminophenyl"

Phrase: ")"

Phrase: "benzofuran"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005068:Benzofuran [Organic Chemical]
  1000   C0537916:benzofuran [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.299: PIB, Pittsburgh compound B.  

Phrase: "PIB,"

Phrase: "Pittsburgh compound B."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1568156:Pittsburgh compound B [Organic Chemical]
   901   C0010124:Compound B [Hormone,Pharmacologic Substance,Steroid]
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]
Processing 00000000.tx.300: ACKNOWLEDGMENTS  We thank Christine Parker and Gill Brown for help with the radioligand binding assay and electron microscopy and David Powell and David Howlett for helpful discussions.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Christine Parker"

Phrase: "and"

Phrase: "Gill Brown for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "help with the radioligand binding assay"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0034596:Radioligand Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0018896:Help [Social Behavior]
   753   C0243073:assay [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C0599278:radioligand [Indicator, Reagent, or Diagnostic Aid]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "electron microscopy"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "and"

Phrase: "David Powell"

Phrase: "and"

Phrase: "David Howlett for helpful discussions."
Processing 00000000.tx.301: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Vickers, J. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Vickers,"

Phrase: "J."
Processing 00000000.tx.302: C., Dickson, T. 

Phrase: "C., Dickson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.303: C., Adlard, P. 

Phrase: "C., Adlard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.304: A., Saunders, H. 

Phrase: "A.,"

Phrase: "Saunders,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.305: L., King, C. 

Phrase: "L., King,"

Phrase: "C."
Processing 00000000.tx.306: E., and McCormack, G. 

Phrase: "E.,"

Phrase: "and"

Phrase: "McCormack,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.307: (2000) Prog. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.308: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.309: 60, 139165[CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "60,"

Phrase: "139165"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.310: J., and Schenk, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.311: (2003) Annu. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.312: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.313: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.314: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.315: 43, 545584[CrossRef][Medline] [OrderarticleviaInfotrieve] Tolnay, M., and Probst, A. 

Phrase: "43,"

Phrase: "545584"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tolnay,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Probst,"

Phrase: "A."
Processing 00000000.tx.316: (2003) IUBMB. 

Phrase: "(2003"

Phrase: ")"

Phrase: "IUBMB."
Processing 00000000.tx.317: Life 55, 299305[Medline] [OrderarticleviaInfotrieve] Braak, H., and Braak, E. 

Phrase: "Life 55,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0376558:Life [Idea or Concept]
   861   C0450382:55 [Intellectual Product]
   777 E C0595998:lives [Finding]

Phrase: "299305"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Braak,"

Phrase: "E."
Processing 00000000.tx.318: (1991) Acta Neuropathol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.319: 82, 239259[Medline] [OrderarticleviaInfotrieve] Gold, G., Kovari, E., Corte, G., Herrmann, F. 

Phrase: "82,"

Phrase: "239259"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1304897:Gold [Functional Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kovari,"

Phrase: "E.,"

Phrase: "Corte,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Herrmann,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.320: R., Canuto, A., Bussiere, T., Hof, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Canuto,"

Phrase: "A.,"

Phrase: "Bussiere,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538150:HOF [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.321: R., Bouras, C., and Giannakopoulos, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bouras,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Giannakopoulos,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.322: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.323: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.324: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.325: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.326: 60, 946952[Medline] [OrderarticleviaInfotrieve] Nordberg, A. 

Phrase: "60,"

Phrase: "946952"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nordberg,"

Phrase: "A."
Processing 00000000.tx.327: (2004) Lancet Neurol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Lancet Neurol."
Processing 00000000.tx.328: 3, 519527[CrossRef][Medline] [OrderarticleviaInfotrieve] Klunk, W. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "519527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Klunk,"

Phrase: "W."
Processing 00000000.tx.329: E., Wang, Y., Huang, G. 

Phrase: "E.,"

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.330: F., Debnath, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Debnath,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: L., Holt, D. 

Phrase: "L., Holt,"

Phrase: "D."
Processing 00000000.tx.332: P., and Mathis, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Mathis,"

Phrase: "C."
Processing 00000000.tx.333: A. 

Phrase: "A."
Processing 00000000.tx.334: (2001) Life Sci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.335: 69, 14711484[CrossRef][Medline] [OrderarticleviaInfotrieve] Mathis, C. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "14711484"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mathis,"

Phrase: "C."
Processing 00000000.tx.336: A., Wang, Y., Holt, D. 

Phrase: "A.,"

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Holt,"

Phrase: "D."
Processing 00000000.tx.337: P., Huang, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Huang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.338: F., Debnath, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Debnath,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.339: L., and Klunk, W. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Klunk,"

Phrase: "W."
Processing 00000000.tx.340: E. 

Phrase: "E."
Processing 00000000.tx.341: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.342: Med. 

Phrase: "Med."
Processing 00000000.tx.343: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.344: 46, 27402754[CrossRef][Medline] [OrderarticleviaInfotrieve] Kung, M. 

Phrase: "46,"

Phrase: "27402754"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kung,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: P., Hou, C., Zhuang, Z. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zhuang,"

Phrase: "Z."
Processing 00000000.tx.346: P., Zhang, B., Skovronsky, D., Trojanowski, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Skovronsky,"

Phrase: "D."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.347: Q., Lee, V. 

Phrase: "Q., Lee,"

Phrase: "V."
Processing 00000000.tx.348: M., and Kung, H. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.349: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.350: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.351: 956, 202210[CrossRef][Medline] [OrderarticleviaInfotrieve] Zhuang, Z. 

Phrase: "956,"

Phrase: "202210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhuang,"

Phrase: "Z."
Processing 00000000.tx.352: P., Kung, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kung,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: P., Hou, C., Skovronsky, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Skovronsky,"

Phrase: "D."
Processing 00000000.tx.354: M., Gur, T. 

Phrase: "M."

Phrase: ","

Phrase: "Gur,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062006:Gur [Biologically Active Substance,Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.355: L., Plossl, K., Trojanowski, J. 

Phrase: "L., Plossl,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.356: Q., Lee, V. 

Phrase: "Q., Lee,"

Phrase: "V."
Processing 00000000.tx.357: M., and Kung, H. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.358: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.359: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.360: Med. 

Phrase: "Med."
Processing 00000000.tx.361: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.362: 44, 19051914[CrossRef][Medline] [OrderarticleviaInfotrieve] Styren, S. 

Phrase: "44,"

Phrase: "19051914"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Styren,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.363: D., Hamilton, R. 

Phrase: "D."

Phrase: ","

Phrase: "Hamilton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.364: L., Styren, G. 

Phrase: "L., Styren,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.365: C., and Klunk, W. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Klunk,"

Phrase: "W."
Processing 00000000.tx.366: E. 

Phrase: "E."
Processing 00000000.tx.367: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.368: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.369: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.370: 48, 12231232[Abstract/Free FullText] Klunk, W. 

Phrase: "48,"

Phrase: "12231232"

Phrase: "[Abstract/Free FullText"

Phrase: "] Klunk,"

Phrase: "W."
Processing 00000000.tx.371: E., Bacskai, B. 

Phrase: "E.,"

Phrase: "Bacskai,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.372: J., Mathis, C. 

Phrase: "J.,"

Phrase: "Mathis,"

Phrase: "C."
Processing 00000000.tx.373: A., Kajdasz, S. 

Phrase: "A.,"

Phrase: "Kajdasz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: T., McLellan, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McLellan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: E., Frosch, M. 

Phrase: "E.,"

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.376: P., Debnath, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Debnath,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.377: L., Holt, D. 

Phrase: "L., Holt,"

Phrase: "D."
Processing 00000000.tx.378: P., Wang, Y., and Hyman, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.379: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.380: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.381: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.382: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.383: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.384: 61, 797805[Medline] [OrderarticleviaInfotrieve] Kung, H. 

Phrase: "61,"

Phrase: "797805"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.385: F., Lee, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "C."
Processing 00000000.tx.386: W., Zhuang, Z. 

Phrase: "W., Zhuang,"

Phrase: "Z."
Processing 00000000.tx.387: P., Kung, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kung,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.388: P., Hou, C., and Plossl, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Plossl,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.389: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Am. 

Phrase: "Am."
Processing 00000000.tx.391: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.392: Soc. 

Phrase: "Soc."
Processing 00000000.tx.393: 123, 1274012741[CrossRef][Medline] [OrderarticleviaInfotrieve] Agdeppa, E. 

Phrase: "123,"

Phrase: "1274012741"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Agdeppa,"

Phrase: "E."
Processing 00000000.tx.394: D., Kepe, V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petric, A., Cole, G. 

Phrase: "D."

Phrase: ","

Phrase: "Kepe,"

Phrase: "V.,"

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "Flores-Torres,"

Phrase: "S."

Phrase: ","

Phrase: "Satyamurthy,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Petric,"

Phrase: "A.,"

Phrase: "Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.395: M., Small, G. 

Phrase: "M."

Phrase: ","

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.396: W., Huang, S. 

Phrase: "W., Huang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.397: C., and Barrio, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Barrio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683589:barrio [Spatial Concept]

Phrase: "J."
Processing 00000000.tx.398: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.400: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.401: 21, 189 Klunk, W. 

Phrase: "21,"

Phrase: "189 Klunk,"

Phrase: "W."
Processing 00000000.tx.402: E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. 

Phrase: "E.,"

Phrase: "Engler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nordberg,"

Phrase: "A.,"

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Blomqvist,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holt,"

Phrase: "D."
Processing 00000000.tx.403: P., Bergstrom, M., Savitcheva, I., Huang, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bergstrom,"

Phrase: "M."

Phrase: ","

Phrase: "Savitcheva,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Huang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: F., Estrada, S., Ausen, B., Debnath, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Estrada,"

Phrase: "S."

Phrase: ","

Phrase: "Ausen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Debnath,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.405: L., Barletta, J., Price, J. 

Phrase: "L., Barletta,"

Phrase: "J.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.406: C., Sandell, J., Lopresti, B. 

Phrase: "C., Sandell,"

Phrase: "J.,"

Phrase: "Lopresti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.407: J., Wall, A., Koivisto, P., Antoni, G., Mathis, C. 

Phrase: "J.,"

Phrase: "Wall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677535:Wall [Manufactured Object]

Phrase: "A.,"

Phrase: "Koivisto,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Antoni,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mathis,"

Phrase: "C."
Processing 00000000.tx.408: A., and Langstrom, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Langstrom,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.409: (2004) Ann. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.410: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.411: 55, 306319[CrossRef][Medline] [OrderarticleviaInfotrieve] Small, G. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "306319"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Small, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.412: W., Agdeppa, E. 

Phrase: "W., Agdeppa,"

Phrase: "E."
Processing 00000000.tx.413: D., Kepe, V., Satyamurthy, N., Huang, S. 

Phrase: "D."

Phrase: ","

Phrase: "Kepe,"

Phrase: "V.,"

Phrase: "Satyamurthy,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Huang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.414: C., and Barrio, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Barrio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683589:barrio [Spatial Concept]

Phrase: "J."
Processing 00000000.tx.415: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.417: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.418: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.419: 19, 323327[Medline] [OrderarticleviaInfotrieve] Naslund, J., Haroutunian, V., Mohs, R., Davis, K. 

Phrase: "19,"

Phrase: "323327"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Naslund,"

Phrase: "J.,"

Phrase: "Haroutunian,"

Phrase: "V.,"

Phrase: "Mohs,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.420: L., Davies, P., Greengard, P., and Buxbaum, J. 

Phrase: "L., Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.421: D. 

Phrase: "D."
Processing 00000000.tx.422: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.423: Am. 

Phrase: "Am."
Processing 00000000.tx.424: Med. 

Phrase: "Med."
Processing 00000000.tx.425: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.426: 283, 15711577[Abstract/Free FullText] Kung, H. 

Phrase: "283,"

Phrase: "15711577"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.427: F., Kung, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kung,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.428: P., Zhuang, Z. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhuang,"

Phrase: "Z."
Processing 00000000.tx.429: P., Hou, C., Lee, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "C."
Processing 00000000.tx.430: W., Plossl, K., Zhuang, B., Skovronsky, D. 

Phrase: "W., Plossl,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhuang,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Skovronsky,"

Phrase: "D."
Processing 00000000.tx.431: M., Lee, V. 

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.432: M., and Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.433: Q. 

Phrase: "Q."
Processing 00000000.tx.434: (2003) Mol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.435: Imaging Biol. 

Phrase: "Imaging Biol."
Processing 00000000.tx.436: 5, 418426[CrossRef][Medline] [OrderarticleviaInfotrieve] Mathis, C. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "418426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mathis,"

Phrase: "C."
Processing 00000000.tx.437: A., Bacskai, B. 

Phrase: "A.,"

Phrase: "Bacskai,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.438: J., Kajdasz, S. 

Phrase: "J.,"

Phrase: "Kajdasz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.439: T., McLellan, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McLellan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: E., Frosch, M. 

Phrase: "E.,"

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.441: P., Hyman, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.442: T., Holt, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Holt,"

Phrase: "D."
Processing 00000000.tx.443: P., Wang, Y., Huang, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.444: F., Debnath, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Debnath,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.445: L., and Klunk, W. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Klunk,"

Phrase: "W."
Processing 00000000.tx.446: E. 

Phrase: "E."
Processing 00000000.tx.447: (2002) Bioorg. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Bioorg."
Processing 00000000.tx.448: Med. 

Phrase: "Med."
Processing 00000000.tx.449: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.450: Lett. 

Phrase: "Lett."
Processing 00000000.tx.451: 12, 295298[CrossRef][Medline] [OrderarticleviaInfotrieve] Ono, M., Kung, M. 

Phrase: "12,"

Phrase: "295298"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ono,"

Phrase: "M."

Phrase: ","

Phrase: "Kung,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.452: P., Hou, C., and Kung, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.453: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.454: (2002) Nucl. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nucl."
Processing 00000000.tx.455: Med. 

Phrase: "Med."
Processing 00000000.tx.456: Biol. 

Phrase: "Biol."
Processing 00000000.tx.457: 29, 633642[CrossRef][Medline] [OrderarticleviaInfotrieve] Nilsson, M. 

Phrase: "29,"

Phrase: "633642"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nilsson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.458: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.459: (2004) Methods (Orlando) 34, 151160[CrossRef] Cheng, Y., and Prusoff, W. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "(Orlando"

Phrase: ")"

Phrase: "34,"

Phrase: "151160"

Phrase: "[CrossRef"

Phrase: "] Cheng,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Prusoff,"

Phrase: "W."
Processing 00000000.tx.460: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.461: (1973) Biochem. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.462: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.463: 22, 30993108[CrossRef][Medline] [OrderarticleviaInfotrieve] Hong, G., Lockhart, A., Davis, B., Rahmoune, H., Baker, S., Ye, L., Thompson, P., Shou, Y., O'Shaughnessy, K., Ronco, P., and Brown, J. 

Phrase: "22,"

Phrase: "30993108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hong,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "A.,"

Phrase: "Davis,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rahmoune,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Thompson,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Shou,"

Phrase: "Y.,"

Phrase: "O'Shaughnessy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ronco,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J."
Processing 00000000.tx.464: (2003) FASEB J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.465: 17, 19661968[Abstract/Free FullText] Pope, A. 

Phrase: "17,"

Phrase: "19661968"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044577:POPE [Lipid]

Phrase: "A."
Processing 00000000.tx.466: J., Haupts, U. 

Phrase: "J.,"

Phrase: "Haupts,"

Phrase: "U."
Processing 00000000.tx.467: M., and Moore, K. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.468: J. 

Phrase: "J."
Processing 00000000.tx.469: (1999) Drug Discov. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Drug Discov."
Processing 00000000.tx.470: Today 4, 350362[CrossRef][Medline] [OrderarticleviaInfotrieve] Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. 

Phrase: "Today 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]

Phrase: "350362"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Naiki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Higuchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hosokawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Takeda,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.471: (1989) Anal. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.472: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.473: 177, 244249[Medline] [OrderarticleviaInfotrieve] LeVine, H., III (1993) Protein Sci. 

Phrase: "177,"

Phrase: "244249"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] LeVine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "(1993"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.474: 2, 404410[Abstract/Free FullText] Ward, R. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "404410"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.475: V., Jennings, K. 

Phrase: "V., Jennings,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.476: H., Jepras, R., Neville, W., Owen, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jepras,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Neville,"

Phrase: "W.,"

Phrase: "Owen,"

Phrase: "D."
Processing 00000000.tx.477: E., Hawkins, J., Christie, G., Davis, J. 

Phrase: "E.,"

Phrase: "Hawkins,"

Phrase: "J.,"

Phrase: "Christie,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Davis,"

Phrase: "J."
Processing 00000000.tx.478: B., George, A., Karran, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "George,"

Phrase: "A.,"

Phrase: "Karran,"

Phrase: "E."
Processing 00000000.tx.479: H., and Howlett, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Howlett,"

Phrase: "D."
Processing 00000000.tx.480: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.481: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.482: J. 

Phrase: "J."
Processing 00000000.tx.483: 348, 137144[CrossRef][Medline] [OrderarticleviaInfotrieve] Serpell, L. 

Phrase: "348,"

Phrase: "137144"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Serpell,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.484: C. 

Phrase: "C."
Processing 00000000.tx.485: (2000) Biochim. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.486: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.487: Acta 1502, 1630[Medline] [OrderarticleviaInfotrieve] Agdeppa, E. 

Phrase: "Acta 1502,"

Phrase: "1630"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Agdeppa,"

Phrase: "E."
Processing 00000000.tx.488: D., Kepe, V., Petri, A., Satyamurthy, N., Liu, J., Huang, S. 

Phrase: "D."

Phrase: ","

Phrase: "Kepe,"

Phrase: "V.,"

Phrase: "Petri,"

Phrase: "A.,"

Phrase: "Satyamurthy,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "Huang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.489: C., Small, G. 

Phrase: "C., Small, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.490: W., Cole, G. 

Phrase: "W., Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.491: M., and Barrio, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Barrio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683589:barrio [Spatial Concept]

Phrase: "J."
Processing 00000000.tx.492: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: (2003) Neuroscience 117, 723730[CrossRef][Medline] [OrderarticleviaInfotrieve] Suemoto, T., Okamura, N., Shiomitsu, T., Suzuki, M., Shimadzu, H., Akatsu, H., Yamamoto, T., Kudo, Y., and Sawada, T. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuroscience 117,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "723730"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suemoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shiomitsu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Shimadzu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Akatsu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kudo,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Sawada,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.494: (2004) Neurosci. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.495: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.496: 48, 6574[CrossRef][Medline] [OrderarticleviaInfotrieve] Vassar, P. 

Phrase: "48,"

Phrase: "6574"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vassar,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.497: S., and Culling, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Culling,"

Phrase: "C."
Processing 00000000.tx.498: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.499: (1959) Arch. 

Phrase: "(1959"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.500: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.501: 68, 487498[Medline] [OrderarticleviaInfotrieve] Kelenyi, G. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "487498"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kelenyi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.502: (1967) J. 

Phrase: "(1967"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.503: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.504: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.505: 15, 172180[Medline] [OrderarticleviaInfotrieve]

Phrase: "15,"

Phrase: "172180"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

